title: 274S_S8

source_name: Buds from HUES8 Differentiation flask #274

value: Buds (S)


title: C3-rep2.input

status: Public on Oct 24 2018

type: SRA

city: Research Triangle Park

first: Paul

middle: A

last: Wade

state: NC

address: 111 TW Alexander Drive

department: Laboratory of Molecular Carcinogenesis

country: USA

institute: NIEHS

library_source: genomic

data_processing:
For ChIP-seq data, cutadapt v1.2.1 was used to remove adapter from raw reads (parameters -a GATCGGAAGAG -O 5 -q 0), then read pairs were filtered out if average base quality was <20 or if shorter than 30nt after removing adapter.
Reads were mapped against mm9 reference genome with Bowtie v1.2 (parameters: -m 1 -X 1000 --chunkmbs 1024).
Duplicate read pairs were removed via Picard v1.110 MarkDuplicates.jar.
Replicates were combined via Picard v1.110 MergeSamFiles.jar, then downsampled to match lowest read total among the 4 sample conditions (N=33055298).
For visualization of ChIP-seq data, each read pair was converted to a single fragment by filling in the gap between ends, converted to bedGraph format via Bedtools v2.24.0 genomeCoverageBed, then converted to bigWig via UCSC utility bedGraphToBigWig.
Genome_build: mm9
Supplementary_files_format_and_content: Genomic depth after merging replicates and downsampling; format=bigWig.

molecule: genomic DNA

organism: Mus musculus

source_name: liver

growth_protocol: Animals were housed in a pathogen-free environment, and no pathogens were identified in sentinel testing of serum and feces. At 20 weeks, all animals were euthanized by carbon dioxide asphyxiation. All animal studies were approved by the Alion Animal Care and Use Committee.

extract_protocol:
Chromatin was  fragmented by sonication with Covaris S220. Immunoprecipitation  was performed with FOXA1 antibody (abcam, ab5089)
NEXTflex Rapid DNA-Seq Library Prep Kit

treatment_protocol: Frozen livers were fixed with 1% formaldehyde at room temperature for 10 min. The fixed tissues were treated with a hypotonic buffer. Nuclei were resuspended with a lysis buffer containing 20 mM Tris-  HCl pH 8.0, 2 mM EDTA, 0.5 mM EGTA, 0.5 mM PMSF,  5 mM sodium butyrate, 0.1 % SDS and protease inhibitor  cocktail).

tag: strain

tag: Sex

value: male

tag: replicate animal

tag: chip antibody


title: 270L_S5

city: Seattle

first: Raghav

last: Chawla

state: WA

address: 3720 15th Ave NE

department: Department of Genome Sciences

institute: University of Washington

library_source: transcriptomic

data_processing:
Paired-end sequencing reads were aligned to the human genome version GRCh38 and quantified with RSEM using the STAR alignment algorithm with default settings.
Genome_build: GRCh38
Supplementary_files_format_and_content: Expected counts per gene from the RSEM output

molecule: total RNA

organism: Homo sapiens

source_name: Bulks from HUES8 Differentiation flask #270

extract_protocol:
Buds were detached and separated from the spheroids at stage 5 of the differentiation protocol by mechanical agitation and filtering. RNA-sequencing of buds versus bulks was performed on samples from 5 separate differentiation flasks, whereby bulks could be collected from all and buds from 3 of the differentiation flasks.
Polyadenylated RNA was selected from total RNA using the PrepX PolyA mRNA Isolation Kit (Takara Bio USA) and sequencing libraries were prepared using the PrepX RNA-Seq for Illumina Library Kit (Takara Bio USA). After additional enrichment, indexing and cleanup steps, libraries were sequenced on an Illumina NextSeq 500.

tag: cell line

tag: differentiation flask number

tag: bulks (large) vs. buds (small)

value: Bulks (L)


title: 270S_S6

source_name: Buds from HUES8 Differentiation flask #270


title: C3-rep3.FOXA1_ChIP

value: FOXA1 (abcam, ab5089)


title: GM6_24_73408

city: Ann Arbor

first: William

middle: R

last: Swindell

state: MI

address: 1500 E. Medical Center Drive

department: Dermatology

institute: University of Michigan

description: RNA extracted from SH-SY5Y neuroblastoma cells

data_processing:
Cutadapt was used to remove Illumina adaptor sequence (AGATCGGAAGAGC) with maximum error rate (-e) of 5% and minimum read length (-m) of 20 base pairs .
To remove sequences mapping to rRNA, an initial tophat2 run was carried out using an edited gtf file specifying only rRNA sequence coordinates for the UCSC GRCh38/hg38 genome sequence, with 1 transcriptome alignment reported per read (-g 1 --transcriptome-only) and disabling of coverage-based junction search (--no-coverage-search). Further analyses were then performed using only the unmapped reads from this preliminary tophat2 run.
Cutadapt was used to trim reads from the 3’ end using a quality score threshold of 30 (-q) and minimum read length of 20. Reads were then filtered using the Fastx toolkit function fastq_quality_filter to retain only those reads with quality scores above 30 for at least 50% of base pairs (settings: -q 30 -p 50).
tophat2 was used to map remaining reads to the UCSC GRCh38/hg38 transcriptome (--transcriptome-only) with disabling of read multi-mapping (-g 1) and coverage-based junction search (--no-coverage-search)
Read counts for each GRCh38/hg38 human gene were tabulated using htseq-count, with reads assigned to a gene only when the alignment quality was greater than 10 (-a 10) and when the read completely and unambiguously overlapped a gene’s sequence (-m intersection-strict). FPKM values and 95% confidence intervals were calculated using Cufflinks with default settings.
Genome_build: GRCh38/hg38
Supplementary_files_format_and_content: Processed data includes raw read counts and FPKM values for all human genes (GRCh38/hg38) and each sample (.txt files).

source_name: SH-SY5Y cells

growth_protocol: Subconfluent SH-SY5Y cells (Sigma, St. Louis, MO) were grown using supplemented Eagle's Minimum Essential / F12 (1:1) Medium.

extract_protocol:
RNA extractions were performed using the NucleoSpin RNA II kit (Machery-Nagel; Bethlehem, PA) with the DNA digestion step and robotic Qiacube (Qiagen, Valencia, CA) workstation. Purified total RNA was assessed at 260nm and 280nm with a NanoDrop Lite (Thermo Fisher Scientific, Waltham, MA) spectrophotometer.
Polyadenylated RNA was purified and used to prepare complementary DNA libraries for high throughput sequencing using the Illumina mRNA-Seq kit according to the manufacturer’s protocol (Illumina, San Diego, CA). Sequencing of fragmented complementary cDNA was performed using the Illumina Genome Analyzer Iix

treatment_protocol: The experiments were performed at Sunny BioDiscovery laboratories (Santa Paula, CA). The test material (GM6 peptide) was dissolved in cell culture medium and tested at a final concentration of 1mg/ml for incubation times of 6, 24 or 48 hours. Subconfluent SH-SY5Y cells (Sigma, St. Louis, MO) were incubated with GM6 in the supplemented Eagle's Minimum Essential / F12 (1:1) Medium. Experiments were terminated after microscopic observation of cells through Nikon (Tokyo, Japan) Eclipse TS100 inverted microscope.

value: SH-SY5Y cells

tag: treatment

tag: time point

value: 24 hours


title: CTL_24_73413

value: CTL


title: C3-rep1.input


title: C3-rep2.FOXA1_ChIP


title: CTL_6_73404

value: 6 hours


title: 264S_S4

source_name: Buds from HUES8 Differentiation flask #264


title: 261L_S2

source_name: Bulks from HUES8 Differentiation flask #261


title: 252L_S1

source_name: Bulks from HUES8 Differentiation flask #252


title: CTL_6_73403


title: GM6_6_73401


title: B6-rep2.input


title: CTL_6_73402


title: B6-rep3.input


title: GM6_6_73399


title: GM6_6_73400


title: B6-rep3.FOXA1_ChIP


title: GM6_6_73397


title: B6-rep1.input


title: B6-rep2.FOXA1_ChIP


title: B6-rep1.FOXA1_ChIP


title: GM6_24_73407


title: C3-rep1.FOXA1_ChIP


title: 264L_S3

source_name: Bulks from HUES8 Differentiation flask #264


title: Col-0_H3K9m2 ChIP_rep2

status: Public on Oct 23 2018

city: West Lafayette

first: Jian-Kang

last: Zhu

state: IN

address: 625 Agriculture Mall Dr.

department: Department of Horticulture and Landscape Architecture

institute: Purdue University

data_processing:
ChIP-Seq: Reads were mapped to TAIR10 by Bowtie2 with parameter "-k 10 --very-sensitive --no-unal --no-mixed --no-discordant", duplicated reads were removed using samtools rmdup.
Genome_build: TAIR10
Supplementary_files_format_and_content: For ChIP-Seq:  The bedGraph files were generated using genomeCoverageBed from bedtools with parameter  -bg -pc

organism: Arabidopsis thaliana

source_name: Col-0_H3K9m2, seedlings

growth_protocol: All plants were grown under a long-day photoperiod with 16 hours of light at 22˚C and 8 hours of darkness at 20˚C.

extract_protocol: 1 g of 10-day-old agdp1 plants and wild-type control were cross-linked with 1% formaldehyde for 20 min and ground into fine powder in liquid nitrogen. Chromatin was isolated and sheared into 200 to 500 bp fragments by sonication. The sonicated chromatin was incubated with 2 µg of anti-H3K9me2 (Abcam, ab1220)/anti-H3 (Abcam, ab1791) antibody and 25 ul Dynabeads Protein G for 5 hours. The precipitated chromatin DNA was then recovered and purified with a standard phenol–chloroform method. ChIP samples were sent to the Genomics Core Facilities of the PSC (Shanghai Center for Plant Stress Biology, Shanghai, China) for library construction according to the manufacturer’s (Illumina) instructions and libraries were sequenced on an Illumina Hiseq 2500 platform.

tag: genotype/variation

value: wild-type control

tag: tissue

value: seedlings

value: anti-H3K9me2 (Abcam, ab1220)


title: F-AGDP1 Input rep2

data_processing:
MethylC-Seq:Reads were mapped to TAIR10 using BRAT-BW v2.0.1 with parameters -m 2 -i 0 -a 1000. Copy-duplicates were remove using remove-dupl command of BRAT-BW. acgt-count command of BRAT-BW was used to count mapped Cs and Ts at each cytosine of forward and reverse strands of the reference
mRNA-Seq: Reads were mapped to TAIR10 by TopHat2.
ChIP-Seq: Reads were mapped to TAIR10 by Bowtie2 with parameter "-k 10 --very-sensitive --no-unal --no-mixed --no-discordant", duplicated reads were removed using samtools rmdup.
Genome_build: TAIR10
Supplementary_files_format_and_content: For MethylC-Seq: The wig files give methylation level for all Cs(three contexts) with depth >= 4. Methylation level of each cytosine base was calculated according to number of converted and unconverted C mapped at that position (unconverted_C / ( converted_C+ unconverted_C ) ).
Supplementary_files_format_and_content: For mRNA-Seq: The bedGraph files were generated using genomeCoverageBed from bedtools with parameter  -bg -split
Supplementary_files_format_and_content: For ChIP-Seq:  The bedGraph files were generated using genomeCoverageBed from bedtools with parameter  -bg -pc

source_name: seedlings

extract_protocol: 1 g of 10-day-old proAGDP1::3xFlag-gAGDP1 transgenic plants and wild-type control were cross-linked with 1% formaldehyde for 20 min and ground into fine powder in liquid nitrogen. Chromatin was isolated and sheared into 200 to 500 bp fragments by sonication. The sonicated chromatin was incubated with 2 µg of anti-Flag antibody and 25 ul Dynabeads Protein G for 5 hours. The precipitated chromatin DNA was then recovered and purified with a standard phenol–chloroform method. ChIP samples were sent to the Genomics Core Facilities of the PSC (Shanghai Center for Plant Stress Biology, Shanghai, China) for library construction according to the manufacturer’s (Illumina) instructions and libraries were sequenced on an Illumina Hiseq 2500 platform.


title: Col-0_H3K9m2 ChIP_rep1


title: agdp1_H3 ChIP_rep2

source_name: agdp1_H3, seedlings

value: agdp1 mutant

value: anti-H3 (Abcam, ab1791)


title: F-AGDP1 Input rep1


title: agdp1_H3 ChIP_rep1


title: agdp1_H3K9m2 ChIP_rep2

source_name: agdp1_H3K9m2, seedlings


title: Col-0_H3 ChIP_rep2

source_name: Col-0_H3, seedlings


title: Col-0_H3 ChIP_rep1


title: F-AGDP1 ChIP rep2


title: F-AGDP1 ChIP rep1


title: suvh456 mRNA-Seq rep3

extract_protocol: Total RNA was extracted from 0.2g of 10-day-old Arabidopsis seedlings with Trizol reagent (Invitrogen) and sent to the Genomics Core Facilities of the PSC (Shanghai Center for Plant Stress Biology, Shanghai, China) for library preparation according to the manufacturer’s (Illumina) instructions.


title: Col-0 Input rep2


title: GM6_6_73398


title: suvh456 mRNA-Seq rep2


title: Col-0 Input rep1


title: agdp1_H3K9m2 ChIP_rep1


title: agdp1-1 mRNA-Seq rep5


title: agdp1-1 mRNA-Seq rep4


title: Col-0 ChIP rep1


title: agdp1-1 mRNA-Seq rep3


title: agdp1-1 mRNA-Seq rep2


title: agdp1-1 mRNA-Seq rep1


title: Col-0 mRNA-Seq rep5


title: Col-0 mRNA-Seq rep4


title: Col-0 ChIP rep2


title: Col-0 MethylC-Seq

description: treated with bisulfite

extract_protocol: Genomic DNA was extracted from 10-day-old seedlings using the DNeasy Plant Maxi Kit (Qiagen, 68163) and sent to the Genomics Core Facilities of the PSC (Shanghai Center for Plant Stress Biology, Shanghai, China) for bisulfite treatment. Libraries were prepared for sequencing according to the manufacturer’s (Illumina) instructions and sequenced on an Illumina Hiseq 2500 platform.


title: suvh456 mRNA-Seq rep1


title: Col-0 mRNA-Seq rep3


title: agdp1-1 MethylC-Seq

description: treated with bisulfite


title: Col-0 mRNA-Seq rep2


title: Col-0 mRNA-Seq rep1


title: N252

city: Columbia

first: Thomas

last: Spencer

state: MO

address: 920 East Campus Drive

department: Animal Sciences

institute: University of Missouri

description: FOXA2 chromatin immunoprecipitated DNA sequencing

data_processing:
The raw sequences were assessed by FastQC tool for data quality.
The program fqtrim (https://ccb.jhu.edu/software/fqtrim/) was used to perform quality trimming (phred score >30) by a sliding window scan (6 nucleotides), and to remove reads that are less than 20 nucleotides in length.
Reads were aligned to the human genome (hg38) using the BWA algorithm (default settings).
The post-alignment quality control steps including removing PCR duplications, number of mismatches, and uniquely mapped reads were performed using the binary alignment files (BAM files) by Picard (https://broadinstitute.github.io/picard/) and Homer (http://homer.ucsd.edu/homer/) tools  as per ENCODE guidelines.
Peak locations were determined using the MACS algorithm (v2.1.0) with a cutoff of p-value = 0.01.
Genome_build: hg38
Supplementary_files_format_and_content: bedgrapgh. It conatins peak cordinates and read pileups.

source_name: endometrium

extract_protocol:
Endometrial specimens were collected from normal volunteers using a Pipelle™ suction device (CooperSurgical) in an outpatient clinic setting. Samples were apportioned to flash freezing in liquid nitrogen and formalin for fixation and later paraffin embedding. Mid-secretory (MS) phase samples were collected 6-10 days after urinary detection of the LH surge and proliferative (P) phase samples were collected between 8-12 days after onset of menses.
Illumina sequencing libraries were prepared from the ChIP and Input DNAs by the standard consecutive enzymatic steps of end-polishing, dA-addition, and adaptor ligation. After a final PCR amplification step, the resulting DNA libraries were quantified and sequenced on Illumina’s NextSeq 500

tag: phase

value: proliferative

tag: antibody


title: N293


title: N275

value: mid-secretory


title: N274


title: T47D, SMAD2 binding region after ActA stimulation and Palbo treatment, rep2

city: Tokyo

first: Daizo

last: Koinuma

address: Hongo 7-3-1, Bunkyo-ku

department: Pathology

country: Japan

institute: University of Tokyo

data_processing:
Reference files of the human reference sequence assembly (NCBI Build 37/hg19, February 2009) and GTF annotation file were obtained from iGenomes (http://support.illumina.com/sequencing/sequencing_software/igenome.html)
ChIP-seq reads were trimmed down to 50 bp and were aligned using Bowtie (version 1.1.0) (Langmead et al., 2009) with the command “-S -a --best --strata -v 1 -m 1”.
BAM files were sorted using Picard SortSam (http://picard.sourceforge.net/).
SMAD2 binding regions were identified using MACS2 software (Model based analysis of ChIP-seq) (version 2.0.9) (Zhang et al, 2008) with a default q-value threshold of 0.05.
WIG to bigWig conversion was performed  using UCSC wigToBigWig.
To reduce the size of the bigWig files, regions with value less than 2 were removed using bwtool (Pohl and Beato, 2014) with the command "remove less 2".
Genome_build: hg19
Supplementary_files_format_and_content: BED and WIG files were generated using MACS2 (version 2.0.9).

source_name: A human breast cancer cell line, T47D

growth_protocol: T47D was obtained from ATCC, and maintained as reccomended. Briefly, T47D cells were cultured at 37°C and 5% CO2 in RPMI 1640 medium (Gibco, Thermo Fisher Scientific) supplemented with 10% (v/v) fetal bovine serum (FBS) (HyClone, GE Healthcare Life Sciences, Piscataway, NJ, USA), 0.2 U/ml insulin (Gibco) and 100 U/ml penicillin-streptomycin (Gibco).

extract_protocol:
Chromatin isolation, sonication and immunoprecipitation using anti-SMAD2 antibody (EP567Y, ab207451, Abcam) was performed essentially as described (Isogaya K et al., Cell Res, 2014; Morikawa M et al., Stem Cell Rep, 2016).
The libraries were constructed as described (Murai et al, Cell Discov, 2015), using IonXpress Plus Fragment Library Kit (Thermo Fisher Scientific). Adaptor-ligated samples were amplified by 15 cycles of PCR and purified by E-Gel SizeSelect (Thermo Fisher Scientific).

treatment_protocol: Cells were treated with Recombinant human Activin A (R&D Systems) with/without Palbociclib/PD0332991 (Sigma-Aldrich).

tag: breast cancer subtype

value: estrogen receptor positive breast cancer (luminal type)

value: Palbo, 1microM, 24h, ActA, 50 ng/ml, 1.5h, replicate 2


title: T47D Palbo 48h

description: gene expression values are in the q2_FPKM column of genes.fpkm_tracking file

data_processing:
Reference files of the human genome hg19 (NCBI build 37, Feb. 2009) and GTF annotation file were obtained from iGenomes (http://support.illumina.com/sequencing/sequencing_software/igenome.html).
RNA-seq reads were aligned and gene expression levels in fragments per kilobase of exon per million fragments mapped (FPKM) were estimated using Tophat/Cufflinks (version 2.0.10 and 2.1.1, respectively) with the default parameter settings (Trapnell et al., 2012).
BAM files were sorted using Picard SortSam (http://picard.sourceforge.net/).
WIG to bigWig conversion was performed  using "samtools depth" combined with "UCSC wigToBigWig".
Genome_build: hg19
Supplementary_files_format_and_content: A tab-delimited text file includes FPKM values of genes for each Sample, which was generated by Cufflinks; bigWig files were generated by Tophat and wigToBigWig.

molecule: polyA RNA

growth_protocol: T47D was obtained from ATCC, and maintained as reccomended. Briefly, T47D cells was cultured at 37°C and 5% CO2 in RPMI 1640 medium (Gibco, Thermo Fisher Scientific) supplemented with 10% (v/v) fetal bovine serum (FBS) (HyClone, GE Healthcare Life Sciences, Piscataway, NJ, USA), 0.2 U/ml insulin (Gibco) and 100 U/ml penicillin-streptomycin (Gibco).

extract_protocol:
RNA was isolated using the RNeasy Kit (Qiagen) with the On-Column DNase Digestion Set (Qiagen, Hilden, Germany).
RNA libraries were prepared for sequencing using Dynabeads mRNA DIRECT Purification Kit and the Ion Total RNA-Seq Kit v2 (Thermo Fisher Scientific).

treatment_protocol: Recombinant human Activin A (R&D Systems), Palbociclib/PD0332991 (Sigma-Aldrich)

value: Palbo, 1microM, 48 h


title: T47D, input

description: input genomic DNA used for peak calling by MACS2

value: untreated


title: Hs578T, SMAD2 binding region after ActA stimulation and Palbo treatment rep2

source_name: A human breast cancer cell line, Hs578T

growth_protocol: Hs578T was obtained from ATCC, and maintained as reccomended. Briefly, cells were cultured at 37°C and 5% CO2 in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Thermo Fisher Scientific) supplemented with 10% FBS, 10 μg/ml insulin and 100 U/ml penicillin-streptomycin.

value: triple negative breast cancer

value: anti-SMAD2 antibody (EP567Y, ab207451, Abcam)


title: Hs578T, input_ActA_Palbo

description: input genomic DNA used for peak calling of ActA- and Palbo-treated samples by MACS2

value: Palbo, 1microM, 24h, ActA, 50 ng/ml, 1.5h


title: T47D ActA 24h

description: gene expression values are in the q3_FPKM column of genes.fpkm_tracking file

value: ActA, 50 ng/ml, 24h


title: Hs578T, SMAD2 binding region after ActA stimulation rep2

value: ActA, 50 ng/ml, 1.5h, replicate 2


title: T47D control

description: gene expression values are in the q1_FPKM column of genes.fpkm_tracking file


title: T47D ActA 24h and Palbo 48h

description: gene expression values are in the q4_FPKM column of genes.fpkm_tracking file

value: Palbo, 1microM, 48 h, ActA, 50 ng/ml, 24 h


title: Hs578T, SMAD2 binding region after ActA stimulation rep1

value: ActA, 50 ng/ml, 1.5h, replicate 1


title: T47D, SMAD2 binding region after ActA stimulation, rep2


title: T47D, SMAD2 binding region after ActA stimulation, rep1


title: T47D, SMAD2 binding region after ActA stimulation and Palbo treatment, rep1

value: Palbo, 1microM, 24h, ActA, 50 ng/ml, 1.5h, replicate 1


title: BPA rep1 liver RRBS

city: Los Angeles

first: Xia

last: Yang

state: CA

address: 610 Charles E Young Dr East

institute: UCLA

description: RRBS.liver.ctrl.vs.bpa.txt

data_processing:
Bisulfite-converted reads were processed and aligned to the reference mouse genome (GRCm38/mm10 build) using the bisulfite aligner BSMAP with parameters -v 8 -z 64 -p 4 -q 2 -f 8 -A AGATCGGAAGAGC -D C-CGG -R
MOAB was used for methylation ratio calling with the parameter -p 8
MOAB was used for the identification of differentially methylated CpGs (DMCs) with the parameter -p 8
Genome_build: mm10
Supplementary_files_format_and_content: Tab-delimited text files including the average methylation ratio for each DMCs in control and BPA groups, as well as relevant statistics for differential methylation

source_name: Liver

growth_protocol: Inbred C57BL/6 mice were maintained on a special diet 5V01 (LabDiet), certified to contain less than 150ppm estrogenic isoflavones, and housed under standard housing conditions (room temperature 22–24°C) with 12:12 hr light:dark cycle before mating at 8-10 weeks of age.

extract_protocol:
A total of 18 DNA samples were isolated from gonadal adipose, hypothalamus and liver tissues from male offspring using the AllPrep DNA/RNA Mini Kit (QIAGEN GmbH, Hilden, Germany). The DNA samples were quantified using the dsDNA BR assay (Qubit, Waltham, MA) and 100ng of DNA was used for library preparation.
After digestion of the DNA with the MspI enzyme, samples underwent an end-repair and adenylation process, followed by adapter ligation using the Truseq barcode adapter (Illumina, San Diego, CA), size selection using AMPure Beads (Beckman Coulter, Brea, CA), and bisulfite treatment using the Epitect Kit (Qiagen, Germantown, MD). Bisulfite-treated DNA was then amplified using the Truseq Library Prep Kit (Illumina, San Diego, CA) and sequenced with the Illumina Hiseq2500 System.

treatment_protocol: Upon mating, female mice were randomly assigned to either the BPA treatment group or the control group. From 1-day post-conception (dpc) to 20 dpc, BPA (Sigma-Aldrich, St. Louis, MO) dissolved in corn oil was administered to pregnant female mice via oral gavage (mimicking common exposure route in humans) at 5mg/kg/day on a daily basis. Control mice were fed the same amount of empty vehicle. BPA exposure was restricted to experimental manipulation through the use of polycarbonate-free water bottles and cages. Offspring from each treatment were maintained on a standard chow diet (Newco Distributors Inc, Rancho Cucamonga, CA). Offspring in the vehicle- and BPA-treated groups were derived from 3 and 4 litters by different dams, respectively, to help assess and adjust for litter effects.

value: Liver

tag: age

value: 3 weeks

value: BPA


title: BPA rep2 liver RRBS

description: RRBS.liver.ctrl.vs.bpa.txt


title: WT rep3 liver RRBS

description: RRBS.liver.ctrl.vs.bpa.txt

value: Corn oil


title: BPA rep3 liver RRBS

description: RRBS.liver.ctrl.vs.bpa.txt


title: WT rep2 liver RRBS

description: RRBS.liver.ctrl.vs.bpa.txt


title: BPA rep3 hypothalamus RRBS

description: RRBS.hypo.ctrl.vs.bpa.txt

source_name: Hypothalamus

value: Hypothalamus


title: Hs578T, input_ActA

description: input genomic DNA used for peak calling of ActA-treated samples by MACS2

value: ActA, 50 ng/ml, 1.5h


title: Hs578T, SMAD2 binding region after ActA stimulation and Palbo treatment rep1


title: BPA rep2 hypothalamus RRBS

description: RRBS.hypo.ctrl.vs.bpa.txt


title: WT rep3 hypothalamus RRBS

description: RRBS.hypo.ctrl.vs.bpa.txt


title: WT rep2 hypothalamus RRBS

description: RRBS.hypo.ctrl.vs.bpa.txt


title: WT rep1 hypothalamus RRBS

description: RRBS.hypo.ctrl.vs.bpa.txt


title: BPA rep2 adipose RRBS

description: RRBS.adipose.ctrl.vs.bpa.txt

source_name: Gonadal adipose

value: Gonadal adipose


title: BPA rep1 adipose RRBS

description: RRBS.adipose.ctrl.vs.bpa.txt


title: WT rep3 adipose RRBS

description: RRBS.adipose.ctrl.vs.bpa.txt


title: WT rep1 adipose RRBS

description: RRBS.adipose.ctrl.vs.bpa.txt


title: BPA rep1 hypothalamus RNA-Seq

data_processing:
Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence, then mapped to mm10 whole genome using HISAT v0.1.6 with parameters -p 8
StringTie v1.0.4 was used to assemble and merge transcripts with parameters -p 8
Transcript abundances were estimated and read coverage tables were generated using StringTie v1.0.4 with parameters -p 8 -b -e
Genome_build: mm10
Supplementary_files_format_and_content: Expression measurements at the gene and transcript level for adipose, hypothalamus and liver tissue in spreadsheet format

extract_protocol:
A total of 18 RNA samples were isolated from gonadal adipose, hypothalamus and liver tissues from male offspring using the AllPrep DNA/RNA Mini Kit (QIAGEN GmbH, Hilden, Germany).
Samples were processed for library preparation using TruSeq RNA Library Preparation Kit (Illumina, San Diego, CA) for poly-A selection, fragmentation, and reverse transcription using random hexamer-primers to generate first-strand cDNA. Second-strand cDNA was generated using RNase H and DNA polymerases, and sequencing adapters were ligated using the Illumina Paired-End sample prep kit. Library products of 250-400bp fragments were isolated, amplified, and sequenced with Illumina Hiseq2500 System.


title: BPA rep3 liver RNA-Seq


title: BPA rep1 liver RNA-Seq


title: BPA rep2 liver RNA-Seq


title: BPA rep3 adipose RRBS

description: RRBS.adipose.ctrl.vs.bpa.txt


title: WT rep3 liver RNA-Seq


title: WT rep1 liver RNA-Seq


title: WT rep2 adipose RRBS

description: RRBS.adipose.ctrl.vs.bpa.txt


title: BPA rep2 adipose RNA-Seq


title: WT rep2 hypothalamus RNA-Seq


title: BPA rep3 adipose RNA-Seq


title: BPA rep1 hypothalamus RRBS

description: RRBS.hypo.ctrl.vs.bpa.txt


title: WT rep1 hypothalamus RNA-Seq


title: WT rep1 liver RRBS

description: RRBS.liver.ctrl.vs.bpa.txt


title: BPA rep1 adipose RNA-Seq


title: WT rep1 adipose RNA-Seq


title: WT rep3 adipose RNA-Seq


title: WT rep3 hypothalamus RNA-Seq


title: WT rep2 adipose RNA-Seq


title: WT rep2 liver RNA-Seq


title: BPA rep2 hypothalamus RNA-Seq


title: Myc_p53null_#4

city: New York

first: Yu-Jui

last: Ho

state: New York

address: 417 E 68th St

department: Cancer Biology & Genetics Program

institute: Memorial Sloan Kettering Cancer Center

description: A06_S102 Myc_p53null_#4

data_processing:
Rnaseq reads were aligned to (GRCm38 - mm10) with STAR (v2.5.0a)
Genome wide transcript counting was performed by featureCounts (v1.6.0) to generate raw count table
Differential expression analysis was performed with DESeq2 (v1.22.1) package in R
Genome_build: GRCm38 - mm10
Supplementary_files_format_and_content: csv text file includes raw count value for each sample

source_name: p53 null hepatocytes transduced with MYC transposons

extract_protocol:
RNA was extracted using the RNAeasy mini kit (Qiagen) per manufacturer's instructions.
RNA integrity and concentration were assessed using a BioAnalyzer (Agilent).  RNA sequencing libraries were generated using Illumina mRNA TruSeq kit with dual index barcoding.

treatment_protocol: Hepatocytes transduced with MYC transposons delivered by hydrodynamic tail vein injection and isolated 6 days after injection via liver perfusion.

tag: strain background

tag: cell type

value: primary mouse hepatocytes

tag: p53 status

value: p53 null

value: transduced with MYC transposons in vivo


title: Myc_p53null_#1

description: A04_S100 Myc_p53null_#1


title: Myc_p53null_#3

description: A05_S101 Myc_p53null_#3


title: Myc_WT_#4

description: A09_S105 Myc_WT_#4

source_name: p53 WT hepatocytes transduced with MYC transposons

value: p53 wt


title: Myc_WT_#5

description: A10_S106 Myc_WT_#5


title: Myc_WT_#2

description: A07_S103 Myc_WT_#2


title: KB25_WT_B

city: Boston

first: Kevin

last: Bi

state: MA

address: 450 Brookline Ave.

department: Pediatric Oncology

institute: Dana-Farber Cancer Institute

data_processing:
Sequence reads were aligned to the mm10 genome assembly using the STAR aligner version 2.3.1z4
BAM files were sorted using Samtools and filtered to retain only primary alignments
Reads were quantified as gene level integer counts using featureCounts
Gene level integer counts were normalized for library size using DESeq2
Genome_build: mm10
Supplementary_files_format_and_content: Raw counts were obtained using featureCounts and normalized counts were obtained using DESeq2

source_name: BW5147  T-cell line

growth_protocol: BW5147 T-cells were maintained at a density of 0.5-1 x 106 cells in a T75 flask in high glucose DMEM medium (Sigma-Aldrich) supplemented with 20 % (v/v) fetal bovine serum (FBS) (Sigma-Aldrich), 100 U/ml penicillin, 100 U/ml streptomycin (Life technologies), 2 mM glutamine (Life technologies).

extract_protocol:
RNA was extracted from the T-cells using the RNeasy kit (QIAGEN) following the manufacturer instructions and total RNA was quantified using the Qubit RNA Assay Kit (Life Tech) and RNAquality was determined on the Bioanalyzer using the RNA Pico Kit (Agilent).
The NuGen Ovation Human RNA-Seq Multiplex system (NuGen, part 0341) Prep Kit, was used to target deletion of unwanted high abundance transcripts and ribosomal RNA. More than 100ng of total RNA was converted into each DNA library following the manufacturer’s protocol without modification. Following library construction, DNA libraries were quantified using the Qubit High Sensitivity DNA Kit (Life Tech) and library size was determined using the Bioanalyzer High Sensitivity Chip Kit (Agilent). Finally, qPCR was carried-out on the libraries using the Universal Library Quantification Kit for Illumina (Kapa Biosystems) and run on the 7900HT Fast qPCR machine (ABI). Libraries passing quality control were diluted to 2nM in sterile water and then sequenced on the NextSeq500 (Illumina) at a final concentration of 12pM, following all manufacturer protocols.

tag: strain

value: AKR/J

value: Lymphoma T-cell line

tag: passages

value: wild type


title: KB24_WT_A


title: KB22_K256L_A

source_name: BW5147  T-cell line with TCRα K256L mutation

value: TCRalpha R251L mutation


title: KB21_R251L_B

source_name: BW5147  T-cell line with TCRα R251L mutation


title: KB19_G259L.N261A_A

source_name: BW5147  T-cell line with TCRα G259L/N261A mutation

value: TCRalpha G259L/N261A mutation


title: KB20_R251L_A


title: KB23_K256L_B


title: KB18_K256L_C

value: TCRalpha K256L mutation


title: KB17_K256L_B


title: KB16_K256L_A


title: KB15_WT_C


title: KB14_WT_B


title: KB13_WT_A


title: pancreas: wt2

city: Nashville

first: Ken

last: Lau

state: TN

address: 2215 Garland Ave. MRBIV10475

department: Cell and Developmental Biology

institute: Vanderbilt University

data_processing:
After sequencing, reads were filtered, sorted by their barcode of origin and aligned to the reference transcriptome using inDrops pipeline (https://github.com/indrops/indrops). Mapped reads were quantified into UMI-filtered counts per gene, and barcodes that correspond to cells were retrieved based on previously established methods
Barcodes with number of unique UMIs greater than a threshold (Klein et al., 2015) were selected, resulting in the processed data table.
Technical read: read2 - UMI/cell barcode - the oligo barcodes are inDrop Version 2 which is positioned exactly as in (Klein et al. 2015)
Biological read: read1 - 3' end
Genome_build: Mouse: GRCm38.85
Supplementary_files_format_and_content: Delimited tables, with cells and genes, as columns and rows

source_name: pancreas

growth_protocol: primary cells

extract_protocol:
Mouse islets were isolated and endocrine cells were enriched by flow sorting for Ngn3eGFP low and high (please refer to paper). Cells were > 95% viable so did not enrich with MACs. Cells were encapsulated using the inDrop platform (1CellBio), and RNA was extracted according to the protocol of Klein et al., 2015.
CEL-Seq linear amplification of RNA/cDNA followed by index primer-based amplification
RNA-Seq was performed on NextSeq500 with a 2 x 75 paired-end kit using custom read lengths

value: pancreas

value: E14.5 pancreatic islet

tag: genotype


title: pancreas: wt1


title: KB12_G259L.N261A_C

tag: cell line


title: KB10_G259L.N261A_A


title: KB11_G259L.N261A_B


title: colon: adjnorm1

source_name: adjacent normal

extract_protocol:
Mouse tumor fragments were isolated using a filtering protocol (see paper). Mouse epithelial cell suspensions were obtained by EDTA extraction and Collagenase/DNAse dissociation. Viable cells were enriched with MACS. Cells were encapsulated using the inDrop platform (1CellBio), and RNA was extracted according to the protocol of Klein et al., 2015.
CEL-Seq linear amplification of RNA/cDNA followed by index primer-based amplification
RNA-Seq was performed on NextSeq500 with a 2 x 75 paired-end kit using custom read lengths

value: colon

value: normal colon


title: aCGH data of J4: Aspergillus oryzae strain bearing a 1.4Mb translocated chromosomal duplication

type: genomic

city: Noda City

first: Tadashi

last: Takahashi

address: 399 Noda

institute: Noda Institute for Scientific Research

description: aCGH J4 vs RIB40

hyb_protocol: 5 ug each of the Cy-dye labeled DNAs (reference and test) were combined with 5 ug of Human Cot-1 DNA (Invitrogen). The mixture was hybridized with Agilent_017367 NISR Aspergillus oryzae 24K v.2.0 (GPL16017) using Oligo aCGH/ChIP-on-chip Hybridization Kit (Agilent Technologies). Hybridization was performed at 65ºC for 24 hours. Then, the array slides were washed with Oligo aCGH/ChIP Wash Buffer Kit (Agilent Technologies).

scan_protocol: The array slide was scanned at 5 µm resolution with an Agilent Microarray Scanner G2505B (Agilent Technologies).

data_processing: Raw microarray image files were processed using Feature Extraction Software version 11.5.1.1(Agilent Technologies). In this process, linear and LOWESS normalizations were carried out to remove the dye-biases of the data.

organism: Aspergillus oryzae

label_protocol:
The sample genomic DNA was sheared to approximately 500 bp using Bioruptor UCD-250HSA (Cosmo Bio). 1 μg of the fragmented genomic DNA was labeled with Cy3 using Genomic DNA Labeling Kit Plus (Agilent technologies). The fragmented DNA was mixed with random primers. The mixture was denatured at 95ºC for 5 minutes, and then immediately cooled on ice. After addition of dNTPs, Cy3-dUTP and, Klenow fragment, the sample was incubated at 37ºC for 2 hours. The labeling reaction was stopped by heat treatment at 65 ºC for 5 min. The Unincorporated nucleotides were removed from the labeled sample by filtration using Millipore Microcon YM-30 filter units, and the sample was further concentrated by YM30 filter units.
The sample genomic DNA was sheared to approximately 500 bp using Bioruptor UCD-250HSA (Cosmo Bio). 1 μg of the fragmented genomic DNA was labeled with Cy5 using Genomic DNA Labeling Kit Plus (Agilent technologies). The fragmented DNA was mixed with random primers. The mixture was denatured at 95ºC for 5 minutes, and then immediately cooled on ice. After addition of dNTPs, Cy5-dUTP and, Klenow fragment, the sample was incubated at 37ºC for 2 hours. The labeling reaction was stopped by heat treatment at 65 ºC for 5 min. Unincorporated nucleotides were removed from the labeled sample by filtration using Millipore Microcon YM-30 filter units, and the sample was further concentrated by YM30 filter units.

growth_protocol: Conidia of A. oryzae RIB40 were inoculated into 40 ml of Polypeptone dextrin (PD) medium (polypeptone 10 g, dextrin 20 g, KH2PO4 5 g, NaNO3 1 g, MgSO4 0.5 g, casamino acid 1 g, per liter; pH 6.0), and incubated at 30°C for 3 days with shaking at 150 rpm. The mycelia were collected by filtration

extract_protocol: The sample was frozen and ground in liquid nitrogen using a mortar and pestle. Genomic DNA of the sample was extracted using Nuclei Lysis Solution (Promega) and Protein precipitation solution (Promega). To remove the contamination of RNA, the genomic DNA sample was treated with RNaseA (Nippon Gene), and the sample was further purified by Genomic-tip 20/G column (QIAGEN).

value: Aspergillus oryzae RIB40 (ATCC42149)

value: Wild type strain

value: Asprgillus oryzae J4

value: translocated duplication of 1.4Mb of Ch2


title: aCGH data of I-8: Aspergillus oryzae strain bearing a 1.4Mb translocated chromosomal triplication

description: aCGH I-8 vs RIB40

value: Asprgillus oryzae I-8

value: translocated triplication of 1.4Mb of Ch2


title: colon: tumor1

source_name: tumor

value: colonic adenoma


title: R17020087LR01: U87 shGlud1-1

city: Guangzhou

first: Xiongjun

last: Wang

address: 230 Wai Huan Xi Road

country: China

institute: Guangzhou University

data_processing:
Illumina Casava1.7 software used for basecalling.
Sequenced reads were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence, then mapped to mm8 whole genome using bowtie v0.12.2.
Reads Per Kilobase of exon per Megabase of library size (RPKM) were calculated using a protocol from Chepelev et al., Nucleic Acids Research, 2009. In short, exons from all isoforms of a gene were merged to create one meta-transcript. The number of reads falling in the exons of this meta-transcript were counted and normalized by the size of the meta-transcript and by the size of the library.

source_name: U87 cell line

growth_protocol: Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% bovine calf serum (HyClone, Logan, UT, USA)

extract_protocol:
1 μg of total RNA was subjected to library synthesis using the TruSeq V2 RNA-Seq kit.  1 μg of total RNA was enriched for the Poly-A mRNA and reverse transcribed to double-stranded cDNA. The cDNA was end repaired, adenylated, and ligated with Illumina indexes prior to 12 cycles of PCR. Sequencing was performed using 12pM hybridization to a 2x150 paired end flow cell.
RNA libraries were prepared for sequencing using standard Illumina protocols

treatment_protocol: Cells were treated with low glucose for 6 hours.

value: glioma

value: Glud1 knock-down


title: R17020088LR01: U87 shGlud1-2


title: R17020085LR01: U87 shNT-1

value: control


title: R17020086LR01: U87 shNT-2


title: HPB-ALL shSHQ1 rep3

city: Wuhan

first: Hudan

last: Liu

address: No.185, Donghu Road

institute: Wuhan University

description: HPB.All.Gene.RPKM.txt

data_processing:
Illumina Casava1.8 software used for basecalling.
Sequenced reads were trimmed for adaptor sequence, dropped short  or low-quality sequence using Trimmomatic (version 0.36) with default settings ,
Clean reads were mapped to hg38 genome using STAR (version 2.5.4b) with default parameters. The database file of splice junctions was downloaded from GENCODE (gencode.v27.basic.annotation.gtf). Duplicate reads were removed with the Picard-tools software package (version 2.18.7).
Reads distribution was calculated using featureCounts (v1.6.2) with paramerters -d 50 -D 1000 -C -s 0 --primary -O -M --fraction. Reads Per Kilobase of exon per Megabase (RPKM) were called using edgeR version 3.22.3.
Genome_build: hg38
Supplementary_files_format_and_content: rpkm files are tab-delimited text files and were generated using edgeR  include RPKM values for each sample in HPB and KOPTK groups.

source_name: T-ALL cells

extract_protocol:
Total RNA was isolated using Trizol reagent (Thermo Fisher Scientific) and RNA samples were rRNA depleted.
RNA libraries were prepared for sequencing using standard Illumina protocols

treatment_protocol: KOPTK1 or HPB-ALL cells were infected with pLKO.1-shRNA against SHQ1 or GFP control lentiviruses, and cultured for 48 h in the presence of puromycin (2 μg/mL).

value: HPB-ALL

value: T-ALL

tag: shRNA transduced


title: HPB-ALL shSHQ1 rep1

description: HPB.All.Gene.RPKM.txt


title: HPB-ALL shSHQ1 rep2

description: HPB.All.Gene.RPKM.txt


title: HPB-ALL Control rep3

description: HPB.All.Gene.RPKM.txt

value: shGFP


title: HPB-ALL Control rep2

description: HPB.All.Gene.RPKM.txt


title: NOK-2

city: Richmond

first: Iain

last: Morgan

state: VA

address: School of Dentistry, W. Baxter Perkinson Bldg, 521 N 11th Street

institute: VIRGINIA COMMONWEALTH UNIVERSITY

data_processing:
Quality control assessed using FastQC version 0.11.2.  All files passed.
Human reference Homo_sapiens.GRCH38.dna_sm.primary_assembly.fa, downloaded from Ensembl http://useast.ensembl.org/info/data/ftp/index.html on July 25, 2016 along with the corresponding .gtf file.  A reference was created using bowtie 2.2.9 build command.
Single-end reads were locally aligned using bowtie2 version 2.2.9 and all other default settings
Mapped to human reads were separated from the rest using awk 'BEGIN{FS =OFS = "\t"} $3 != "*"' inputfile >outputfile
The human mapped reads were sorted using samtools sort command
Libraries used in R version 3.2 for the remaining workflows are GenomicFeatures 1.24.5, Genomic Alignments 1.8.4, and DESeq2 version 1.12.4
BAM files and .gtf file downloaded above were fed into DESeq2 as well as sample information, and a gene level analysis was performed.  (colData = read.csv(FG_comp, row.names=1)) and (txdb = makeTxDbFromGFF(gtffile, format = "gtf", circ_seqs = character())) and (ebg <- exonsBy(txdb, by="gene")) and FGse <- summarizeOverlaps(features=ebg, reads=bamfiles, mode="Union", singleEnd=TRUE, ignore.strand=TRUE, fragments=FALSE ) and T1 = (as.data.frame(assay(FGse)))
H1 = DESeqDataSetFromMatrix(countData = T1, colData = colData, design = ~ Condition)
Genes were considered differentially expressed if DESeq2's adjusted p-value was < 0.05 and fold change >1.5 fold in magnitude
Genome_build: Human reference Homo_sapiens.GRCH38.dna_sm.primary_assembly.fa, downloaded from Ensembl http://useast.ensembl.org/info/data/ftp/index.html on July 25, 2016
Supplementary_files_format_and_content: Tab delimited text matrix of abdundance measurements as outputted by DESeq2

source_name: Normal Oral Keratinocytes

growth_protocol: Cells were grown in keratinocyte serum-free medium (K-SFM) (Gibco) with 1% (v/v) penicillin/streptomycin mixture (Life Technologies) containing 4μg/mL hygromycin B (Sigma) at 37°C in a 5% CO2/95% air atmosphere and passaged every 3-4 days. Cells were routinely checked for mycoplasma contamination. NOKs+E2 clones and NOKs+HPV16 clones were grown in medium containing 150μg/mL G418 (Corning). NOKs+E2, NOKs+E6, and NOKs+E7 and NTERT+E2 pools were grown in medium containing 5 μg/mL puromycin (Corning).

extract_protocol:
1x106 cells were plated onto 100mm plates, trypsinized and pelleted after 24hrs and washed twice with phosphate buffered saline (PBS). RNA was immediately isolated using the SV Total RNA Isolation System (Promega) following the manufacturer’s instructions.
RNA was extracted using the same method described for SYBR Green qRT-PCR above. RNA sequencing was performed by the Genomics, Epigenomics and Sequencing core at the University of Cincinnati under the supervision of Dr. Xiang Zhang. Duplicates were sequenced for NOKs and NOKs+HPV16. The RNA concentration was measured by Nanodrop (Thermo Scientific) and its integrity was determined by Bioanalyzer (Agilent). The NEBNext Ultra Directional RNA Library Prep Kit (New England BioLabs) was used for library preparation, which used dUTP in cDNA synthesis to maintain strand specificity. In short, the isolated polyA RNA or rRNA/globin depleted RNA was Mg2+/heat fragmented (∼200 bp), reverse transcribed to 1st strand cDNA, followed by 2nd strand cDNA synthesis labelled with dUTP. The purified cDNA was end repaired and dA tailed, and then ligated to adapter with a stem-loop structure. The dUTP-labelled 2nd strand cDNA was removed by USER enzyme to maintain strand specificity. After indexing via PCR (∼12 cycles) enrichment, the amplified libraries together with library preparation negative control were cleaned up by AMPure XP beads for QC analysis. To check the quality and yield of the purified library, one µl library was analyzed by Bioanalyzer (Agilent) using DNA high sensitivity chip. To accurately quantify the library concentration for the clustering, the library was 1:104 diluted in dilution buffer (10 mM Tris-HCl, pH 8.0 with 0.05% Tween 20), and qPCR measured by Kapa Library Quantification kit (Kapabiosystem) using ABI’s 9700HT real-time PCR system (Thermo Fisher). Individually indexed and compatible libraries were proportionally pooled (∼25 million reads per sample) for clustering in cBot system (Illumina). Libraries at the final concentration of 15 pM were clustered onto a single read (SR) flow cell using Illumina TruSeq SR Cluster kit v3, and sequenced to 50 bp using TruSeq SBS kit on Illumina HiSeq system.

treatment_protocol: 2.5x105 cells were plated onto 10cm plates. The following day 1 μM Decitabine (Abcam - ab120842) was added to media of cells. 96 hours later, cells were harvested by trypsinization and processed for qRT-PCR or western blotting as described above.

value: Normal Oral Keratinocytes

value: Control


title: NOK HPV16-FG27-1

value: HPV16 full genome


title: NOK HPV16-FG27-2


title: NOK HPV16-E2V10-1

value: overexpressing HPV16 E2 protein


title: NOK HPV16-E2V10-2


title: NOK HPV16-E2V7-2


title: NOK-1


title: HPB-ALL Control rep1

description: HPB.All.Gene.RPKM.txt


title: NOK HPV16-E2V7-1


title: Heart Wild Type_3

type: RNA

city: Miami

first: Lina

last: Shehadeh

state: FL

department: Medicine

institute: University of Miami

hyb_protocol: Affymetrix FlashTag Biotin HSR RNA Labeling Kit (P/N 901910)

scan_protocol: Command ConsoleTM User Guide (P/N 702569); GeneChip Scanner 3000 7G system; GeneChip Command Console Software (AGCC)

data_processing:
Expression ratios were calculated in Genespring 13.0 as the power-2 exponential of the log2 differences. The acceptance criteria for gene array expression changes was a minimum 2 fold change in log2 (equivalent to 4 fold) and a one-way Analysis of Variance (ANOVA) t-test with Benjamini-Hochberg multiple testing correction p-value of <0.05.
Summarization Algorithm: RMA Technology:  Affymetrix.ExonExprChip.MoGene-2_0-st.  Normalization: Quantile Baseline Transformation: median of all samples

label: FlashTag™ Biotin HSR RNA Labeling Reagent

source_name: Heart Wild Type

extract_protocol: RNA was extracted from freshly snap frozen hearts using Mirvana Paris kit.

treatment_protocol: Hearts were snap frozen from 2 month old wild type (n=3), Col4a3-/- (n=3), or Col4a3-/-OPN-/- (n=3) mice. RNA was isolated using Mirvana Paris kit.

value: Heart Wild Type

value: heart


title: Heart Wild Type_1

label_protocol: Affymetrix FlashTag Biotin HSR RNA Labeling Kit (P/N 901910)


title: Heart Col4a3-/-OPN-/-_2

source_name: Heart Col4a3-/-OPN-/-

value: Heart Col4a3-/-OPN-/-


title: Heart Col4a3-/-_3

source_name: Heart Col4a3-/-

value: Heart Col4a3-/-


title: Heart Col4a3-/-_1


title: Heart Col4a3-/-OPN-/-_3


title: Heart Wild Type_2


title: Heart Col4a3-/-OPN-/-_1


title: Heart Col4a3-/-_2


title: KOPTK1 shSHQ1 rep3

description: KOPTK.All.Gene.RPKM.txt


title: KOPTK1 shSHQ1 rep2

description: KOPTK.All.Gene.RPKM.txt


title: KOPTK1 shSHQ1 rep1

description: KOPTK.All.Gene.RPKM.txt


title: KOPTK1 Control rep3

description: KOPTK.All.Gene.RPKM.txt


title: KOPTK1 Control rep2

description: KOPTK.All.Gene.RPKM.txt


title: KOPTK1 Control rep1

description: KOPTK.All.Gene.RPKM.txt


title: BPA rep3 hypothalamus RNA-Seq

source_name: Hypothalamus

value: Hypothalamus

value: 3 weeks

value: BPA


title: Sarcoma SA1007

city: Kanagawa

first: Satoko

last: Takizawa

address: kamakurashi

institute: Toray industries inc

description:
Sarcoma
SH51905_Cell2

hyb_protocol: Hybridized for 16 h at 32 ºC with rotary shaker (250 rpm). Hybridization buffer and washing protocol was attached in the 3D-Gene® miRNA oligo chip kit.

scan_protocol: 3D-Gene® Scanner (Toray Industries, Inc.) was used for scanning. Images were quantified using Extraction version 2.0.0.6 (Toray Industries, Inc.).

data_processing: The presence of miRNA was determined based on a corresponding microarray signal of greater than [the mean + 2 × standard deviation] of the negative controls signal, of which the top and bottom ranked ones by signal intensity were removed. Once a miRNA was considered present, the mean signal of the negative controls of which the top and bottom 5% ranked by signal intensity were removed was subtracted from the miRNA signal. When the signal value was negative (or undetEsophageal Cancerted) after background subtraction, the value was replaced by 0.1 on a base 2 logarithm scale.

source_name: Serum

label_protocol: miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.

extract_protocol: Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.).

tag: tumor stage (figo)

value: uncertain


title: Sarcoma SA0995

description:
Sarcoma
SH51867_Cell2


title: Sarcoma SA0992

description:
Sarcoma
SH51864_Cell3


title: Sarcoma SA0918

description:
Sarcoma
SH4YT64_Cell1


title: Sarcoma SA0903

description:
Sarcoma
SH4YT59_Cell2


title: Sarcoma SA0971

description:
Sarcoma
SH51857_Cell2


title: Sarcoma SA0972

description:
Sarcoma
SH51857_Cell3


title: Sarcoma SA0902

description:
Sarcoma
SH4YT59_Cell1


title: Sarcoma SA0965

description:
Sarcoma
SH51854_Cell4


title: Sarcoma SA0957

description:
Sarcoma
SH51851_Cell4


title: Sarcoma SA0955

description:
Sarcoma
SH51851_Cell2


title: Sarcoma SA0900

description:
Sarcoma
SH4YT58_Cell3


title: Sarcoma SA0901

description:
Sarcoma
SH51P39_Cell4


title: Sarcoma SA0884

description:
Sarcoma
SH4YT53_Cell3


title: Sarcoma SA0898

description:
Sarcoma
SH4YT58_Cell1


title: Sarcoma SA0891

description:
Sarcoma
SH4YT56_Cell2


title: Sarcoma SA0888

description:
Sarcoma
SH4YT54_Cell3


title: Sarcoma SA0872

description:
Sarcoma
SH4YT50_Cell3


title: Sarcoma SA0886

description:
Sarcoma
SH4YT54_Cell1


title: Sarcoma SA0921

description:
Sarcoma
SH4YT64_Cell4


title: Sarcoma SA0864

description:
Sarcoma
SH4YT47_Cell3


title: Sarcoma SA0949

description:
Sarcoma
SH51848_Cell4


title: Sarcoma SA0866

description:
Sarcoma
SH4YT49_Cell1


title: Sarcoma SA0739

description:
Sarcoma
SH51P18_Cell3


title: Sarcoma SA0856

description:
Sarcoma
SH51P36_Cell2


title: Sarcoma SA0535

description:
Sarcoma
SH52108_Cell4


title: Sarcoma SA0867

description:
Sarcoma
SH4YT49_Cell2


title: Sarcoma SA0882

description:
Sarcoma
SH4YT53_Cell1


title: Sarcoma SA0469

description:
Sarcoma
SH59X28_Cell3


title: Sarcoma SA0464

description:
Sarcoma
SH59X27_Cell2


title: Sarcoma SA0461

description:
Sarcoma
SH59X26_Cell3


title: Sarcoma SA0456

description:
Sarcoma
SH59X25_Cell2


title: Sarcoma SA0455

description:
Sarcoma
SH59X25_Cell1


title: Sarcoma SA0446

description:
Sarcoma
SH59X22_Cell4


title: Sarcoma SA0453

description:
Sarcoma
SH59X24_Cell3


title: Sarcoma SA0442

description:
Sarcoma
SH59X21_Cell4


title: Sarcoma SA0445

description:
Sarcoma
SH59X22_Cell3


title: Sarcoma SA0440

description:
Sarcoma
SH59X21_Cell2


title: Sarcoma SA0431

description:
Sarcoma
SH59X19_Cell4


title: Sarcoma SA0441

description:
Sarcoma
SH59X21_Cell3


title: Sarcoma SA0427

description:
Sarcoma
SH59X18_Cell4


title: Sarcoma SA0447

description:
Sarcoma
SH59X23_Cell1


title: Sarcoma SA0429

description:
Sarcoma
SH59X19_Cell2


title: Sarcoma SA0422

description:
Sarcoma
SH59X17_Cell3


title: Sarcoma SA0426

description:
Sarcoma
SH59X18_Cell3


title: Sarcoma SA0416

description:
Sarcoma
SH59X16_Cell1


title: Sarcoma SA0450

description:
Sarcoma
SH59X23_Cell4


title: Sarcoma SA0417

description:
Sarcoma
SH59X16_Cell2


title: Sarcoma SA0419

description:
Sarcoma
SH59X16_Cell4


title: Sarcoma SA0418

description:
Sarcoma
SH59X16_Cell3


title: Sarcoma SA0412

description:
Sarcoma
SH59X15_Cell2


title: Sarcoma SA0407

description:
Sarcoma
SH59X14_Cell1


title: Sarcoma SA0399

description:
Sarcoma
SH59X12_Cell1


title: Sarcoma SA0404

description:
Sarcoma
SH59X13_Cell2


title: Sarcoma SA0398

description:
Sarcoma
SH59X11_Cell4


title: Sarcoma SA0424

description:
Sarcoma
SH59X18_Cell1


title: Sarcoma SA0397

description:
Sarcoma
SH59X11_Cell3


title: Myc_WT_#3

description: A08_S104 Myc_WT_#3

value: primary mouse hepatocytes

value: p53 wt

tag: treatment

value: transduced with MYC transposons in vivo


title: Sarcoma SA0387

description:
Sarcoma
SH59X08_Cell2


title: Sarcoma SA0379

description:
Sarcoma
SH59X06_Cell2


title: Sarcoma SA0377

description:
Sarcoma
SH59X05_Cell4


title: Sarcoma SA0361

description:
Sarcoma
SH59X02_Cell1


title: Sarcoma SA0400

description:
Sarcoma
SH59X12_Cell2


title: Sarcoma SA0374

description:
Sarcoma
SH59X05_Cell1


title: Sarcoma SA0360

description:
Sarcoma
SH59X01_Cell4


title: Sarcoma SA0335

description:
Sarcoma
SH59W57_Cell4


title: Sarcoma SA0362

description:
Sarcoma
SH59X02_Cell2


title: Sarcoma SA0337

description:
Sarcoma
SH59W58_Cell2


title: Sarcoma SA0304

description:
Sarcoma
SH59W50_Cell1


title: Sarcoma SA0322

description:
Sarcoma
SH59W54_Cell3


title: Sarcoma SA0325

description:
Sarcoma
SH59W55_Cell2


title: Sarcoma SA0351

description:
Sarcoma
SH59W61_Cell4


title: Sarcoma SA0307

description:
Sarcoma
SH59W50_Cell4


title: Sarcoma SA0346

description:
Sarcoma
SH59W60_Cell3


title: Sarcoma SA0319

description:
Sarcoma
SH59W53_Cell4


title: Sarcoma SA0330

description:
Sarcoma
SH59W56_Cell3


title: Sarcoma SA0297

description:
Sarcoma
SH59W48_Cell2


title: Sarcoma SA0347

description:
Sarcoma
SH59W60_Cell4


title: Sarcoma SA0338

description:
Sarcoma
SH59W58_Cell3


title: Sarcoma SA0296

description:
Sarcoma
SH59W48_Cell1


title: Sarcoma SA0290

description:
Sarcoma
SH59W46_Cell3


title: Sarcoma SA0318

description:
Sarcoma
SH59W53_Cell3


title: Sarcoma SA0273

description:
Sarcoma
SH59W41_Cell3


title: Sarcoma SA0284

description:
Sarcoma
SH59W44_Cell2


title: Sarcoma SA0266

description:
Sarcoma
SH59W40_Cell1


title: Sarcoma SA0286

description:
Sarcoma
SH59W44_Cell4


title: Sarcoma SA0217

description:
Sarcoma
SH59W26_Cell4


title: Sarcoma SA0317

description:
Sarcoma
SH59W53_Cell2


title: Sarcoma SA0309

description:
Sarcoma
SH59W51_Cell2


title: Sarcoma SA0213

description:
Sarcoma
SH59W25_Cell4


title: Sarcoma SA0209

description:
Sarcoma
SH59W25_Cell2


title: Sarcoma SA0184

description:
Sarcoma
SH59W18_Cell3


title: Sarcoma SA0206

description:
Sarcoma
SH59W24_Cell3


title: Sarcoma SA0201

description:
Sarcoma
SH59W23_Cell2


title: Sarcoma SA0162

description:
Sarcoma
SH59W13_Cell4


title: Sarcoma SA0197

description:
Sarcoma
SH59W22_Cell2


title: Sarcoma SA0137

description:
Sarcoma
SH59W09_Cell2


title: Sarcoma SA0154

description:
Sarcoma
SH59W12_Cell2


title: Sarcoma SA0112

description:
Sarcoma
SH59W03_Cell4


title: Sarcoma SA0155

description:
Sarcoma
SH59W12_Cell3


title: Sarcoma SA0099

description:
Sarcoma
SH59W01_Cell2


title: Sarcoma SA0100

description:
Sarcoma
SH59W01_Cell3


title: Sarcoma SA0148

description:
Sarcoma
SH59W11_Cell4


title: Sarcoma SA0095

description:
Sarcoma
SH59Q64_Cell2


title: Sarcoma SA0098

description:
Sarcoma
SH59W01_Cell1


title: Sarcoma SA0066

description:
Sarcoma
SH59Q57_Cell2


title: Sarcoma SA0119

description:
Sarcoma
SH59W05_Cell2


title: Sarcoma SA0091

description:
Sarcoma
SH59Q63_Cell2


title: Sarcoma SA0116

description:
Sarcoma
SH59W04_Cell3


title: Sarcoma SA0081

description:
Sarcoma
SH59Q60_Cell4


title: Sarcoma SA0058

description:
Sarcoma
SH59Q54_Cell2


title: Sarcoma SA0053

description:
Sarcoma
SH59Q53_Cell1


title: Sarcoma SA0060

description:
Sarcoma
SH59Q54_Cell4


title: Pancreatic Cancer PC0865

description:
Pancreatic Cancer
SH56941_Cell4


title: Sarcoma SA0194

description:
Sarcoma
SH59W21_Cell3


title: Sarcoma SA0048

description:
Sarcoma
SH59Q51_Cell4


title: Pancreatic Cancer PC0858

description:
Pancreatic Cancer
SH56940_Cell1


title: Pancreatic Cancer PC0857

description:
Pancreatic Cancer
SH56939_Cell4


title: Sarcoma SA0135

description:
Sarcoma
SH59W09_Cell1


title: Pancreatic Cancer PC0852

description:
Pancreatic Cancer
SH56937_Cell3


title: Pancreatic Cancer PC0850

description:
Pancreatic Cancer
SH56937_Cell1


title: Pancreatic Cancer PC0849

description:
Pancreatic Cancer
SH56936_Cell4


title: Pancreatic Cancer PC0842

description:
Pancreatic Cancer
SH56935_Cell1


title: Pancreatic Cancer PC0834

description:
Pancreatic Cancer
SH54854_Cell1


title: Pancreatic Cancer PC0832

description:
Pancreatic Cancer
SH54825_Cell3


title: Pancreatic Cancer PC0835

description:
Pancreatic Cancer
SH54854_Cell2


title: Pancreatic Cancer PC0840

description:
Pancreatic Cancer
SH56931_Cell3


title: Pancreatic Cancer PC0825

description:
Pancreatic Cancer
SH56951_Cell4


title: Pancreatic Cancer PC0830

description:
Pancreatic Cancer
SH54825_Cell1


title: Pancreatic Cancer PC0836

description:
Pancreatic Cancer
SH54854_Cell3


title: Pancreatic Cancer PC0816

description:
Pancreatic Cancer
SH56950_Cell4


title: Pancreatic Cancer PC0814

description:
Pancreatic Cancer
SH56950_Cell3


title: Pancreatic Cancer PC0813

description:
Pancreatic Cancer
SH56917_Cell4


title: Pancreatic Cancer PC0821

description:
Pancreatic Cancer
SH53S42_Cell4


title: Pancreatic Cancer PC0819

description:
Pancreatic Cancer
SH53S42_Cell2


title: Pancreatic Cancer PC0807

description:
Pancreatic Cancer
SH56916_Cell2


title: Pancreatic Cancer PC0791

description:
Pancreatic Cancer
SH56949_Cell4


title: Pancreatic Cancer PC0796

description:
Pancreatic Cancer
SH56912_Cell3


title: Pancreatic Cancer PC0790

description:
Pancreatic Cancer
SH56949_Cell3


title: Pancreatic Cancer PC0798

description:
Pancreatic Cancer
SH56914_Cell1


title: Pancreatic Cancer PC0803

description:
Pancreatic Cancer
SH56915_Cell2


title: Pancreatic Cancer PC0800

description:
Pancreatic Cancer
SH56914_Cell3


title: Pancreatic Cancer PC0789

description:
Pancreatic Cancer
SH56910_Cell4


title: Pancreatic Cancer PC0788

description:
Pancreatic Cancer
SH56910_Cell3


title: Pancreatic Cancer PC0826

description:
Pancreatic Cancer
SH54643_Cell1


title: Pancreatic Cancer PC0787

description:
Pancreatic Cancer
SH56910_Cell2


title: Pancreatic Cancer PC0785

description:
Pancreatic Cancer
SH56909_Cell4


title: Pancreatic Cancer PC0784

description:
Pancreatic Cancer
SH56909_Cell3


title: Pancreatic Cancer PC0823

description:
Pancreatic Cancer
SH54221_Cell2


title: Pancreatic Cancer PC0783

description:
Pancreatic Cancer
SH56909_Cell2


title: Pancreatic Cancer PC0780

description:
Pancreatic Cancer
SH56908_Cell3


title: Pancreatic Cancer PC0779

description:
Pancreatic Cancer
SH56908_Cell2


title: Pancreatic Cancer PC0799

description:
Pancreatic Cancer
SH56914_Cell2


title: Pancreatic Cancer PC0817

description:
Pancreatic Cancer
SH56951_Cell1


title: Pancreatic Cancer PC0818

description:
Pancreatic Cancer
SH53S42_Cell1


title: Pancreatic Cancer PC0772

description:
Pancreatic Cancer
SH56906_Cell3


title: Pancreatic Cancer PC0776

description:
Pancreatic Cancer
SH56907_Cell3


title: Pancreatic Cancer PC0775

description:
Pancreatic Cancer
SH56907_Cell2


title: Pancreatic Cancer PC0777

description:
Pancreatic Cancer
SH56907_Cell4


title: Pancreatic Cancer PC0767

description:
Pancreatic Cancer
SH56905_Cell2


title: Pancreatic Cancer PC0765

description:
Pancreatic Cancer
SH56903_Cell4


title: Pancreatic Cancer PC0756

description:
Pancreatic Cancer
SH56901_Cell3


title: Pancreatic Cancer PC0750

description:
Pancreatic Cancer
SH56868_Cell1


title: Pancreatic Cancer PC0751

description:
Pancreatic Cancer
SH56868_Cell2


title: Pancreatic Cancer PC0741

description:
Pancreatic Cancer
SH56864_Cell4


title: Pancreatic Cancer PC0743

description:
Pancreatic Cancer
SH56865_Cell2


title: Pancreatic Cancer PC0742

description:
Pancreatic Cancer
SH56865_Cell1


title: Pancreatic Cancer PC0738

description:
Pancreatic Cancer
SH56864_Cell1


title: Pancreatic Cancer PC0740

description:
Pancreatic Cancer
SH56864_Cell3


title: Pancreatic Cancer PC0736

description:
Pancreatic Cancer
SH56863_Cell3


title: Pancreatic Cancer PC0734

description:
Pancreatic Cancer
SH56863_Cell1


title: Pancreatic Cancer PC0732

description:
Pancreatic Cancer
SH56948_Cell1


title: Pancreatic Cancer PC0727

description:
Pancreatic Cancer
SH56946_Cell4


title: Pancreatic Cancer PC0724

description:
Pancreatic Cancer
SH56946_Cell1


title: Pancreatic Cancer PC0731

description:
Pancreatic Cancer
SH56947_Cell4


title: Pancreatic Cancer PC0721

description:
Pancreatic Cancer
SH56945_Cell2


title: Pancreatic Cancer PC0720

description:
Pancreatic Cancer
SH56945_Cell1


title: Pancreatic Cancer PC0715

description:
Pancreatic Cancer
SH56943_Cell4


title: Pancreatic Cancer PC0746

description:
Pancreatic Cancer
SH56866_Cell1


title: Pancreatic Cancer PC0752

description:
Pancreatic Cancer
SH56868_Cell3


title: Pancreatic Cancer PC0712

description:
Pancreatic Cancer
SH56943_Cell2


title: Pancreatic Cancer PC0713

description:
Pancreatic Cancer
SH56856_Cell4


title: Pancreatic Cancer PC0709

description:
Pancreatic Cancer
SH56855_Cell4


title: Pancreatic Cancer PC0711

description:
Pancreatic Cancer
SH56856_Cell2


title: Pancreatic Cancer PC0708

description:
Pancreatic Cancer
SH56855_Cell3


title: Pancreatic Cancer PC0696

description:
Pancreatic Cancer
SH56852_Cell3


title: Pancreatic Cancer PC0701

description:
Pancreatic Cancer
SH56853_Cell4


title: Pancreatic Cancer PC0685

description:
Pancreatic Cancer
SH56849_Cell4


title: Pancreatic Cancer PC0698

description:
Pancreatic Cancer
SH56853_Cell1


title: Pancreatic Cancer PC0697

description:
Pancreatic Cancer
SH56852_Cell4


title: Pancreatic Cancer PC0718

description:
Pancreatic Cancer
SH56944_Cell3


title: Pancreatic Cancer PC0680

description:
Pancreatic Cancer
SH56848_Cell3


title: Pancreatic Cancer PC0728

description:
Pancreatic Cancer
SH56947_Cell1


title: Pancreatic Cancer PC0681

description:
Pancreatic Cancer
SH56848_Cell4


title: Pancreatic Cancer PC0707

description:
Pancreatic Cancer
SH56855_Cell2


title: Pancreatic Cancer PC0684

description:
Pancreatic Cancer
SH56849_Cell3


title: Pancreatic Cancer PC0666

description:
Pancreatic Cancer
SH56844_Cell1


title: Pancreatic Cancer PC0676

description:
Pancreatic Cancer
SH56847_Cell3


title: Pancreatic Cancer PC0665

description:
Pancreatic Cancer
SH56843_Cell4


title: Pancreatic Cancer PC0671

description:
Pancreatic Cancer
SH56845_Cell2


title: Pancreatic Cancer PC0661

description:
Pancreatic Cancer
SH56841_Cell4


title: Pancreatic Cancer PC0660

description:
Pancreatic Cancer
SH56841_Cell3


title: Pancreatic Cancer PC0662

description:
Pancreatic Cancer
SH56843_Cell1


title: Pancreatic Cancer PC0655

description:
Pancreatic Cancer
SH56840_Cell2


title: Pancreatic Cancer PC0663

description:
Pancreatic Cancer
SH56843_Cell2


title: Pancreatic Cancer PC0654

description:
Pancreatic Cancer
SH56840_Cell1


title: Pancreatic Cancer PC0692

description:
Pancreatic Cancer
SH56851_Cell3


title: Pancreatic Cancer PC0695

description:
Pancreatic Cancer
SH56852_Cell2


title: Pancreatic Cancer PC0649

description:
Pancreatic Cancer
SH56942_Cell3


title: Pancreatic Cancer PC0648

description:
Pancreatic Cancer
SH56838_Cell3


title: Pancreatic Cancer PC0646

description:
Pancreatic Cancer
SH56942_Cell1


title: Pancreatic Cancer PC0664

description:
Pancreatic Cancer
SH56843_Cell3


title: Pancreatic Cancer PC0640

description:
Pancreatic Cancer
SH55T65_Cell3


title: Pancreatic Cancer PC0644

description:
Pancreatic Cancer
SH55T67_Cell3


title: Pancreatic Cancer PC0641

description:
Pancreatic Cancer
SH55T65_Cell4


title: Pancreatic Cancer PC0629

description:
Pancreatic Cancer
SH54N07_Cell3


title: Pancreatic Cancer PC0632

description:
Pancreatic Cancer
SH54N08_Cell2


title: Pancreatic Cancer PC0626

description:
Pancreatic Cancer
SH54N06_Cell4


title: Pancreatic Cancer PC0628

description:
Pancreatic Cancer
SH54N07_Cell2


title: Pancreatic Cancer PC0638

description:
Pancreatic Cancer
SH54N23_Cell2


title: Pancreatic Cancer PC0617

description:
Pancreatic Cancer
SH54L68_Cell3


title: Pancreatic Cancer PC0619

description:
Pancreatic Cancer
SH54N05_Cell1


title: Pancreatic Cancer PC0615

description:
Pancreatic Cancer
SH54L68_Cell1


title: Pancreatic Cancer PC0608

description:
Pancreatic Cancer
SH54L66_Cell2


title: Pancreatic Cancer PC0607

description:
Pancreatic Cancer
SH54L66_Cell1


title: Pancreatic Cancer PC0657

description:
Pancreatic Cancer
SH56840_Cell4


title: Pancreatic Cancer PC0633

description:
Pancreatic Cancer
SH54N08_Cell3


title: Pancreatic Cancer PC0603

description:
Pancreatic Cancer
SH54L65_Cell1


title: Pancreatic Cancer PC0602

description:
Pancreatic Cancer
SH54L64_Cell4


title: Pancreatic Cancer PC0600

description:
Pancreatic Cancer
SH54L64_Cell2


title: OV_others OV0417

description:
OV_others
SH67S32_Cell3


title: OV_others OV0176

description:
OV_others
SH57M04_Cell4


title: OV_others OV0248

description:
OV_others
SH57M28_Cell3


title: OV_others OV0158

description:
OV_others
SH57G67_Cell2


title: Ovarian Cancer OV0440

description:
Ovarian Cancer
SH67S40_Cell2


title: Ovarian Cancer OV0442

description:
Ovarian Cancer
SH67S40_Cell4


title: Ovarian Cancer OV0439

description:
Ovarian Cancer
SH67S40_Cell1


title: OV_others OV0022

description:
OV_others
SH56H44_Cell1


title: OV_others OV0118

description:
OV_others
SH56J10_Cell2


title: OV_others OV0153

description:
OV_others
SH57G66_Cell1


title: Ovarian Cancer OV0436

description:
Ovarian Cancer
SH67S39_Cell2


title: Pancreatic Cancer PC0605

description:
Pancreatic Cancer
SH54L65_Cell3


title: OV_others OV0016

description:
OV_others
SH56H42_Cell3


title: OV_others OV0077

description:
OV_others
SH56H65_Cell1


title: Ovarian Cancer OV0430

description:
Ovarian Cancer
SH67S37_Cell4

value: XX


title: Ovarian Cancer OV0433

description:
Ovarian Cancer
SH67S38_Cell3


title: OV_others OV0144

description:
OV_others
SH57G63_Cell4


title: Ovarian Cancer OV0414

description:
Ovarian Cancer
SH67S30_Cell4


title: Ovarian Cancer OV0429

description:
Ovarian Cancer
SH67S37_Cell3


title: OV_others OV0441

description:
OV_others
SH67S40_Cell3


title: Ovarian Cancer OV0423

description:
Ovarian Cancer
SH67S34_Cell1


title: Ovarian Cancer OV0411

description:
Ovarian Cancer
SH67S30_Cell1


title: Ovarian Cancer OV0413

description:
Ovarian Cancer
SH67S30_Cell3


title: Ovarian Cancer OV0416

description:
Ovarian Cancer
SH67S32_Cell2


title: OV_others OV0233

description:
OV_others
SH57M23_Cell4


title: Ovarian Cancer OV0412

description:
Ovarian Cancer
SH67S30_Cell2


title: Ovarian Cancer OV0419

description:
Ovarian Cancer
SH67S33_Cell1


title: Ovarian Cancer OV0410

description:
Ovarian Cancer
SH67S29_Cell4


title: OV_others OV0223

description:
OV_others
SH57M21_Cell2


title: Ovarian Cancer OV0427

description:
Ovarian Cancer
SH67S37_Cell1


title: Ovarian Cancer OV0406

description:
Ovarian Cancer
SH67S28_Cell4


title: Ovarian Cancer OV0405

description:
Ovarian Cancer
SH67S28_Cell3


title: Ovarian Cancer OV0398

description:
Ovarian Cancer
SH67S26_Cell4


title: Ovarian Cancer OV0400

description:
Ovarian Cancer
SH67S27_Cell2


title: Ovarian Cancer OV0402

description:
Ovarian Cancer
SH67S27_Cell4


title: Ovarian Cancer OV0395

description:
Ovarian Cancer
SH67S26_Cell1


title: Ovarian Cancer OV0399

description:
Ovarian Cancer
SH67S27_Cell1


title: Ovarian Cancer OV0403

description:
Ovarian Cancer
SH67S28_Cell1


title: Ovarian Cancer OV0404

description:
Ovarian Cancer
SH67S28_Cell2


title: Ovarian Cancer OV0391

description:
Ovarian Cancer
SH67T19_Cell4


title: Ovarian Cancer OV0397

description:
Ovarian Cancer
SH67S26_Cell3


title: Ovarian Cancer OV0415

description:
Ovarian Cancer
SH67S32_Cell1


title: Ovarian Cancer OV0393

description:
Ovarian Cancer
SH67T20_Cell2


title: Ovarian Cancer OV0392

description:
Ovarian Cancer
SH67T20_Cell1


title: Ovarian Cancer OV0396

description:
Ovarian Cancer
SH67S26_Cell2


title: Ovarian Cancer OV0390

description:
Ovarian Cancer
SH67S23_Cell4


title: Ovarian Cancer OV0389

description:
Ovarian Cancer
SH67S23_Cell3


title: Ovarian Cancer OV0387

description:
Ovarian Cancer
SH67T19_Cell3


title: Ovarian Cancer OV0384

description:
Ovarian Cancer
SH67T19_Cell2


title: Ovarian Cancer OV0386

description:
Ovarian Cancer
SH67S22_Cell4


title: Ovarian Cancer OV0382

description:
Ovarian Cancer
SH67S20_Cell4


title: Ovarian Cancer OV0380

description:
Ovarian Cancer
SH67S20_Cell2


title: Ovarian Cancer OV0383

description:
Ovarian Cancer
SH67S22_Cell1


title: Ovarian Cancer OV0379

description:
Ovarian Cancer
SH67S20_Cell1


title: Ovarian Cancer OV0378

description:
Ovarian Cancer
SH67S19_Cell4


title: Ovarian Cancer OV0401

description:
Ovarian Cancer
SH67S27_Cell3


title: Ovarian Cancer OV0385

description:
Ovarian Cancer
SH67S22_Cell3


title: Ovarian Cancer OV0376

description:
Ovarian Cancer
SH67S19_Cell2


title: Ovarian Cancer OV0375

description:
Ovarian Cancer
SH67S19_Cell1


title: Ovarian Cancer OV0381

description:
Ovarian Cancer
SH67S20_Cell3


title: Ovarian Cancer OV0369

description:
Ovarian Cancer
SH67S16_Cell3


title: Ovarian Cancer OV0351

description:
Ovarian Cancer
SH67S12_Cell1


title: Ovarian Cancer OV0357

description:
Ovarian Cancer
SH67S13_Cell3


title: Ovarian Cancer OV0366

description:
Ovarian Cancer
SH67S15_Cell4


title: Ovarian Cancer OV0368

description:
Ovarian Cancer
SH67S16_Cell2


title: Ovarian Cancer OV0359

description:
Ovarian Cancer
SH67S14_Cell1


title: Ovarian Cancer OV0365

description:
Ovarian Cancer
SH67S15_Cell3


title: Ovarian Cancer OV0371

description:
Ovarian Cancer
SH67S18_Cell1


title: Ovarian Cancer OV0374

description:
Ovarian Cancer
SH67S18_Cell4


title: Ovarian Cancer OV0372

description:
Ovarian Cancer
SH67S18_Cell2


title: Ovarian Cancer OV0360

description:
Ovarian Cancer
SH67S14_Cell2


title: Ovarian Cancer OV0350

description:
Ovarian Cancer
SH67S11_Cell4


title: Ovarian Cancer OV0345

description:
Ovarian Cancer
SH67S09_Cell3


title: Ovarian Cancer OV0340

description:
Ovarian Cancer
SH67T19_Cell1


title: Ovarian Cancer OV0347

description:
Ovarian Cancer
SH67S11_Cell1


title: Ovarian Cancer OV0344

description:
Ovarian Cancer
SH67S09_Cell2


title: Ovarian Cancer OV0349

description:
Ovarian Cancer
SH67S11_Cell3


title: Ovarian Cancer OV0339

description:
Ovarian Cancer
SH67S08_Cell1


title: Ovarian Cancer OV0336

description:
Ovarian Cancer
SH67S06_Cell2


title: Ovarian Cancer OV0338

description:
Ovarian Cancer
SH67S06_Cell4


title: Ovarian Cancer OV0342

description:
Ovarian Cancer
SH67S08_Cell4


title: Ovarian Cancer OV0335

description:
Ovarian Cancer
SH67S06_Cell1


title: Ovarian Cancer OV0355

description:
Ovarian Cancer
SH67S13_Cell1


title: Ovarian Cancer OV0370

description:
Ovarian Cancer
SH67S16_Cell4


title: Ovarian Cancer OV0346

description:
Ovarian Cancer
SH67S09_Cell4


title: Ovarian Cancer OV0343

description:
Ovarian Cancer
SH67S09_Cell1


title: Ovarian Cancer OV0330

description:
Ovarian Cancer
SH67S04_Cell4


title: Ovarian Cancer OV0331

description:
Ovarian Cancer
SH67S05_Cell1


title: Ovarian Cancer OV0332

description:
Ovarian Cancer
SH67S05_Cell2


title: Ovarian Cancer OV0333

description:
Ovarian Cancer
SH67S05_Cell3


title: Ovarian Cancer OV0324

description:
Ovarian Cancer
SH67S03_Cell2


title: Ovarian Cancer OV0327

description:
Ovarian Cancer
SH67S04_Cell1


title: Ovarian Cancer OV0326

description:
Ovarian Cancer
SH67S03_Cell4


title: Ovarian Cancer OV0329

description:
Ovarian Cancer
SH67S04_Cell3


title: Ovarian Cancer OV0319

description:
Ovarian Cancer
SH67S02_Cell1


title: Ovarian Cancer OV0318

description:
Ovarian Cancer
SH67S01_Cell4


title: Ovarian Cancer OV0320

description:
Ovarian Cancer
SH67S02_Cell2


title: Ovarian Cancer OV0321

description:
Ovarian Cancer
SH67S02_Cell3


title: Ovarian Cancer OV0317

description:
Ovarian Cancer
SH67S01_Cell3


title: Ovarian Cancer OV0325

description:
Ovarian Cancer
SH67S03_Cell3


title: Ovarian Cancer OV0315

description:
Ovarian Cancer
SH67S01_Cell1


title: Ovarian Cancer OV0314

description:
Ovarian Cancer
SH67R63_Cell4


title: Ovarian Cancer OV0309

description:
Ovarian Cancer
SH67R62_Cell3


title: Ovarian Cancer OV0313

description:
Ovarian Cancer
SH67R63_Cell3


title: Ovarian Cancer OV0312

description:
Ovarian Cancer
SH67R63_Cell2


title: Ovarian Cancer OV0310

description:
Ovarian Cancer
SH67R62_Cell4


title: Ovarian Cancer OV0311

description:
Ovarian Cancer
SH67R63_Cell1


title: Ovarian Cancer OV0307

description:
Ovarian Cancer
SH67R62_Cell1


title: Ovarian Cancer OV0323

description:
Ovarian Cancer
SH67S03_Cell1


title: Ovarian Cancer OV0304

description:
Ovarian Cancer
SH67R61_Cell2


title: Ovarian Cancer OV0322

description:
Ovarian Cancer
SH67S02_Cell4


title: Ovarian Cancer OV0296

description:
Ovarian Cancer
SH67R59_Cell2


title: Ovarian Cancer OV0295

description:
Ovarian Cancer
SH67R59_Cell1


title: Ovarian Cancer OV0292

description:
Ovarian Cancer
SH67R58_Cell2


title: Ovarian Cancer OV0294

description:
Ovarian Cancer
SH67R58_Cell4


title: Ovarian Cancer OV0291

description:
Ovarian Cancer
SH67R58_Cell1


title: Ovarian Cancer OV0290

description:
Ovarian Cancer
SH67R56_Cell4


title: Ovarian Cancer OV0297

description:
Ovarian Cancer
SH67R59_Cell3


title: Ovarian Cancer OV0308

description:
Ovarian Cancer
SH67R62_Cell2


title: Ovarian Cancer OV0288

description:
Ovarian Cancer
SH67R56_Cell2


title: Ovarian Cancer OV0284

description:
Ovarian Cancer
SH67R55_Cell2


title: Ovarian Cancer OV0274

description:
Ovarian Cancer
SH67R52_Cell4


title: Ovarian Cancer OV0281

description:
Ovarian Cancer
SH67R54_Cell3


title: Ovarian Cancer OV0280

description:
Ovarian Cancer
SH67R54_Cell2


title: Ovarian Cancer OV0283

description:
Ovarian Cancer
SH67R55_Cell1


title: Ovarian Cancer OV0275

description:
Ovarian Cancer
SH67R53_Cell1


title: Ovarian Cancer OV0285

description:
Ovarian Cancer
SH67R55_Cell3


title: Ovarian Cancer OV0273

description:
Ovarian Cancer
SH67R52_Cell3


title: Ovarian Cancer OV0272

description:
Ovarian Cancer
SH67R52_Cell2


title: Ovarian Cancer OV0271

description:
Ovarian Cancer
SH67R52_Cell1


title: Ovarian Cancer OV0258

description:
Ovarian Cancer
SH67T18_Cell2


title: Ovarian Cancer OV0259

description:
Ovarian Cancer
SH67R49_Cell1


title: Ovarian Cancer OV0264

description:
Ovarian Cancer
SH67T18_Cell3


title: Ovarian Cancer OV0257

description:
Ovarian Cancer
SH67T18_Cell1


title: Ovarian Cancer OV0260

description:
Ovarian Cancer
SH67R49_Cell2


title: Ovarian Cancer OV0262

description:
Ovarian Cancer
SH67R49_Cell4


title: Ovarian Cancer OV0261

description:
Ovarian Cancer
SH67R49_Cell3


title: Ovarian Cancer OV0256

description:
Ovarian Cancer
SH67T16_Cell4


title: Ovarian Cancer OV0266

description:
Ovarian Cancer
SH67R50_Cell4


title: Ovarian Cancer OV0255

description:
Ovarian Cancer
SH67R48_Cell1


title: Ovarian Cancer OV0252

description:
Ovarian Cancer
SH57M29_Cell3


title: Ovarian Cancer OV0279

description:
Ovarian Cancer
SH67R54_Cell1


title: Ovarian Cancer OV0254

description:
Ovarian Cancer
SH57M30_Cell1


title: Ovarian Cancer OV0253

description:
Ovarian Cancer
SH57M29_Cell4


title: Ovarian Cancer OV0249

description:
Ovarian Cancer
SH57M28_Cell4


title: Ovarian Cancer OV0250

description:
Ovarian Cancer
SH57M29_Cell1


title: Ovarian Cancer OV0246

description:
Ovarian Cancer
SH57M28_Cell1


title: Ovarian Cancer OV0245

description:
Ovarian Cancer
SH57M27_Cell4


title: Ovarian Cancer OV0247

description:
Ovarian Cancer
SH57M28_Cell2


title: Ovarian Cancer OV0243

description:
Ovarian Cancer
SH57M27_Cell2


title: Ovarian Cancer OV0236

description:
Ovarian Cancer
SH57M24_Cell3


title: Ovarian Cancer OV0235

description:
Ovarian Cancer
SH57M24_Cell2


title: Ovarian Cancer OV0239

description:
Ovarian Cancer
SH57M26_Cell2


title: Ovarian Cancer OV0238

description:
Ovarian Cancer
SH57M26_Cell1


title: Ovarian Cancer OV0229

description:
Ovarian Cancer
SH57M22_Cell4


title: Ovarian Cancer OV0409

description:
Ovarian Cancer
SH67S29_Cell3


title: Ovarian Cancer OV0231

description:
Ovarian Cancer
SH57M23_Cell2


title: Ovarian Cancer OV0241

description:
Ovarian Cancer
SH57M26_Cell4


title: Ovarian Cancer OV0228

description:
Ovarian Cancer
SH57M22_Cell3


title: Ovarian Cancer OV0227

description:
Ovarian Cancer
SH57M22_Cell2


title: Ovarian Cancer OV0225

description:
Ovarian Cancer
SH57M21_Cell4


title: Ovarian Cancer OV0224

description:
Ovarian Cancer
SH57M21_Cell3


title: Ovarian Cancer OV0220

description:
Ovarian Cancer
SH57M20_Cell3


title: Ovarian Cancer OV0226

description:
Ovarian Cancer
SH57M22_Cell1


title: Ovarian Cancer OV0214

description:
Ovarian Cancer
SH57M19_Cell1


title: Ovarian Cancer OV0218

description:
Ovarian Cancer
SH57M20_Cell1


title: Ovarian Cancer OV0244

description:
Ovarian Cancer
SH57M27_Cell3


title: Ovarian Cancer OV0230

description:
Ovarian Cancer
SH57P14_Cell4


title: Ovarian Cancer OV0210

description:
Ovarian Cancer
SH57M18_Cell1


title: Ovarian Cancer OV0216

description:
Ovarian Cancer
SH57M19_Cell3


title: Ovarian Cancer OV0208

description:
Ovarian Cancer
SH57M17_Cell3


title: Ovarian Cancer OV0213

description:
Ovarian Cancer
SH57M18_Cell4


title: Ovarian Cancer OV0211

description:
Ovarian Cancer
SH57M18_Cell2


title: Ovarian Cancer OV0212

description:
Ovarian Cancer
SH57M18_Cell3


title: Ovarian Cancer OV0219

description:
Ovarian Cancer
SH57M20_Cell2


title: Ovarian Cancer OV0222

description:
Ovarian Cancer
SH57M21_Cell1


title: Ovarian Cancer OV0205

description:
Ovarian Cancer
SH57M16_Cell4


title: Ovarian Cancer OV0206

description:
Ovarian Cancer
SH57M17_Cell1


title: Ovarian Cancer OV0198

description:
Ovarian Cancer
SH57M15_Cell1


title: Ovarian Cancer OV0200

description:
Ovarian Cancer
SH57M15_Cell3


title: Ovarian Cancer OV0199

description:
Ovarian Cancer
SH57M15_Cell2


title: Ovarian Cancer OV0193

description:
Ovarian Cancer
SH57M13_Cell4


title: Ovarian Cancer OV0196

description:
Ovarian Cancer
SH57M14_Cell3


title: Ovarian Cancer OV0194

description:
Ovarian Cancer
SH57M14_Cell1


title: Ovarian Cancer OV0204

description:
Ovarian Cancer
SH57M16_Cell3


title: Ovarian Cancer OV0195

description:
Ovarian Cancer
SH57M14_Cell2


title: Ovarian Cancer OV0201

description:
Ovarian Cancer
SH57M15_Cell4


title: Ovarian Cancer OV0191

description:
Ovarian Cancer
SH57M13_Cell2


title: Ovarian Cancer OV0190

description:
Ovarian Cancer
SH57M13_Cell1


title: Ovarian Cancer OV0192

description:
Ovarian Cancer
SH57M13_Cell3


title: Ovarian Cancer OV0189

description:
Ovarian Cancer
SH57P14_Cell2


title: Ovarian Cancer OV0179

description:
Ovarian Cancer
SH57M05_Cell3


title: Ovarian Cancer OV0178

description:
Ovarian Cancer
SH57M05_Cell2


title: Ovarian Cancer OV0183

description:
Ovarian Cancer
SH57M11_Cell2


title: Ovarian Cancer OV0181

description:
Ovarian Cancer
SH57M06_Cell1


title: Ovarian Cancer OV0175

description:
Ovarian Cancer
SH57M04_Cell3


title: Ovarian Cancer OV0185

description:
Ovarian Cancer
SH57P13_Cell2


title: Ovarian Cancer OV0187

description:
Ovarian Cancer
SH57P13_Cell4


title: Ovarian Cancer OV0174

description:
Ovarian Cancer
SH57M04_Cell2


title: Ovarian Cancer OV0173

description:
Ovarian Cancer
SH57M04_Cell1


title: Ovarian Cancer OV0169

description:
Ovarian Cancer
SH57M03_Cell1


title: Ovarian Cancer OV0203

description:
Ovarian Cancer
SH57M16_Cell2


title: Ovarian Cancer OV0172

description:
Ovarian Cancer
SH57M03_Cell4


title: Ovarian Cancer OV0177

description:
Ovarian Cancer
SH57M05_Cell1


title: Ovarian Cancer OV0197

description:
Ovarian Cancer
SH57M14_Cell4


title: Ovarian Cancer OV0168

description:
Ovarian Cancer
SH57M02_Cell4


title: Ovarian Cancer OV0165

description:
Ovarian Cancer
SH57M02_Cell1


title: Ovarian Cancer OV0167

description:
Ovarian Cancer
SH57M02_Cell3


title: Ovarian Cancer OV0166

description:
Ovarian Cancer
SH57M02_Cell2


title: Ovarian Cancer OV0164

description:
Ovarian Cancer
SH57G68_Cell4


title: Ovarian Cancer OV0163

description:
Ovarian Cancer
SH57G68_Cell3


title: Ovarian Cancer OV0160

description:
Ovarian Cancer
SH57G67_Cell4


title: Ovarian Cancer OV0161

description:
Ovarian Cancer
SH57G68_Cell1


title: Ovarian Cancer OV0157

description:
Ovarian Cancer
SH57G67_Cell1


title: Ovarian Cancer OV0159

description:
Ovarian Cancer
SH57G67_Cell3


title: Ovarian Cancer OV0162

description:
Ovarian Cancer
SH57G68_Cell2


title: Ovarian Cancer OV0156

description:
Ovarian Cancer
SH57G66_Cell4


title: Ovarian Cancer OV0155

description:
Ovarian Cancer
SH57G66_Cell3


title: Ovarian Cancer OV0148

description:
Ovarian Cancer
SH57G64_Cell4


title: Ovarian Cancer OV0142

description:
Ovarian Cancer
SH57G63_Cell2


title: Ovarian Cancer OV0145

description:
Ovarian Cancer
SH57G64_Cell1


title: Ovarian Cancer OV0134

description:
Ovarian Cancer
SH57G60_Cell2


title: Ovarian Cancer OV0146

description:
Ovarian Cancer
SH57G64_Cell2


title: Ovarian Cancer OV0138

description:
Ovarian Cancer
SH57G62_Cell2


title: Ovarian Cancer OV0139

description:
Ovarian Cancer
SH57G62_Cell3


title: Ovarian Cancer OV0136

description:
Ovarian Cancer
SH57G60_Cell4


title: Ovarian Cancer OV0129

description:
Ovarian Cancer
SH57G59_Cell1


title: Ovarian Cancer OV0130

description:
Ovarian Cancer
SH57G59_Cell2


title: Ovarian Cancer OV0132

description:
Ovarian Cancer
SH57G59_Cell4


title: Ovarian Cancer OV0133

description:
Ovarian Cancer
SH57G60_Cell1


title: Ovarian Cancer OV0131

description:
Ovarian Cancer
SH57G59_Cell3


title: Ovarian Cancer OV0127

description:
Ovarian Cancer
SH57G58_Cell3


title: Ovarian Cancer OV0152

description:
Ovarian Cancer
SH57G65_Cell4


title: Ovarian Cancer OV0128

description:
Ovarian Cancer
SH57G58_Cell4


title: Ovarian Cancer OV0126

description:
Ovarian Cancer
SH57G58_Cell2


title: Ovarian Cancer OV0124

description:
Ovarian Cancer
SH57G57_Cell4


title: Ovarian Cancer OV0125

description:
Ovarian Cancer
SH57G58_Cell1


title: Ovarian Cancer OV0119

description:
Ovarian Cancer
SH56J10_Cell3


title: Ovarian Cancer OV0149

description:
Ovarian Cancer
SH57G65_Cell1


title: Ovarian Cancer OV0122

description:
Ovarian Cancer
SH57G57_Cell2


title: Ovarian Cancer OV0116

description:
Ovarian Cancer
SH56J08_Cell4


title: Ovarian Cancer OV0114

description:
Ovarian Cancer
SH56J08_Cell2


title: Ovarian Cancer OV0115

description:
Ovarian Cancer
SH56J08_Cell3


title: Ovarian Cancer OV0112

description:
Ovarian Cancer
SH56J07_Cell4


title: Ovarian Cancer OV0113

description:
Ovarian Cancer
SH56J08_Cell1


title: Ovarian Cancer OV0109

description:
Ovarian Cancer
SH57P12_Cell4


title: Ovarian Cancer OV0110

description:
Ovarian Cancer
SH56J07_Cell2


title: Ovarian Cancer OV0111

description:
Ovarian Cancer
SH56J07_Cell3


title: Ovarian Cancer OV0107

description:
Ovarian Cancer
SH56J05_Cell3


title: Ovarian Cancer OV0103

description:
Ovarian Cancer
SH56J03_Cell3


title: Ovarian Cancer OV0101

description:
Ovarian Cancer
SH56J03_Cell1


title: Ovarian Cancer OV0120

description:
Ovarian Cancer
SH56J10_Cell4


title: Ovarian Cancer OV0117

description:
Ovarian Cancer
SH56J10_Cell1


title: Ovarian Cancer OV0121

description:
Ovarian Cancer
SH57G57_Cell1


title: Ovarian Cancer OV0102

description:
Ovarian Cancer
SH56J03_Cell2


title: Ovarian Cancer OV0099

description:
Ovarian Cancer
SH57P12_Cell2


title: Ovarian Cancer OV0106

description:
Ovarian Cancer
SH56J05_Cell2


title: Ovarian Cancer OV0095

description:
Ovarian Cancer
SH56J01_Cell3


title: Ovarian Cancer OV0094

description:
Ovarian Cancer
SH56J01_Cell2


title: Ovarian Cancer OV0098

description:
Ovarian Cancer
SH57P12_Cell1


title: Ovarian Cancer OV0143

description:
Ovarian Cancer
SH57G63_Cell3


title: Ovarian Cancer OV0097

description:
Ovarian Cancer
SH57P10_Cell4


title: Ovarian Cancer OV0084

description:
Ovarian Cancer
SH56H66_Cell4


title: Ovarian Cancer OV0080

description:
Ovarian Cancer
SH56H65_Cell4


title: Ovarian Cancer OV0093

description:
Ovarian Cancer
SH56J01_Cell1


title: Ovarian Cancer OV0085

description:
Ovarian Cancer
SH56H67_Cell1


title: Ovarian Cancer OV0089

description:
Ovarian Cancer
SH56H68_Cell1


title: Ovarian Cancer OV0083

description:
Ovarian Cancer
SH56H66_Cell3


title: Ovarian Cancer OV0081

description:
Ovarian Cancer
SH56H66_Cell1


title: Ovarian Cancer OV0105

description:
Ovarian Cancer
SH56J05_Cell1


title: Ovarian Cancer OV0079

description:
Ovarian Cancer
SH56H65_Cell3


title: Ovarian Cancer OV0082

description:
Ovarian Cancer
SH56H66_Cell2


title: Ovarian Cancer OV0078

description:
Ovarian Cancer
SH56H65_Cell2


title: Ovarian Cancer OV0090

description:
Ovarian Cancer
SH56H68_Cell2


title: Ovarian Cancer OV0073

description:
Ovarian Cancer
SH56H64_Cell1


title: Ovarian Cancer OV0076

description:
Ovarian Cancer
SH56H64_Cell4


title: Ovarian Cancer OV0070

description:
Ovarian Cancer
SH56H63_Cell2


title: Ovarian Cancer OV0065

description:
Ovarian Cancer
SH56H62_Cell1


title: Ovarian Cancer OV0072

description:
Ovarian Cancer
SH56H63_Cell4


title: Ovarian Cancer OV0069

description:
Ovarian Cancer
SH56H63_Cell1


title: Ovarian Cancer OV0059

description:
Ovarian Cancer
SH57P10_Cell1


title: Ovarian Cancer OV0062

description:
Ovarian Cancer
SH56H60_Cell2


title: Ovarian Cancer OV0068

description:
Ovarian Cancer
SH56H62_Cell4


title: Ovarian Cancer OV0066

description:
Ovarian Cancer
SH56H62_Cell2


title: Ovarian Cancer OV0061

description:
Ovarian Cancer
SH56H60_Cell1


title: Ovarian Cancer OV0067

description:
Ovarian Cancer
SH56H62_Cell3


title: Ovarian Cancer OV0054

description:
Ovarian Cancer
SH56H58_Cell2


title: Ovarian Cancer OV0056

description:
Ovarian Cancer
SH56H58_Cell4


title: Ovarian Cancer OV0058

description:
Ovarian Cancer
SH57P09_Cell4


title: Ovarian Cancer OV0057

description:
Ovarian Cancer
SH57P09_Cell3


title: Ovarian Cancer OV0051

description:
Ovarian Cancer
SH57P09_Cell1


title: Ovarian Cancer OV0053

description:
Ovarian Cancer
SH56H58_Cell1


title: Ovarian Cancer OV0055

description:
Ovarian Cancer
SH56H58_Cell3


title: Ovarian Cancer OV0048

description:
Ovarian Cancer
SH56H55_Cell4


title: Ovarian Cancer OV0044

description:
Ovarian Cancer
SH56H49_Cell3


title: Ovarian Cancer OV0071

description:
Ovarian Cancer
SH56H63_Cell3


title: Ovarian Cancer OV0043

description:
Ovarian Cancer
SH56H49_Cell2


title: Ovarian Cancer OV0075

description:
Ovarian Cancer
SH56H64_Cell3


title: Ovarian Cancer OV0064

description:
Ovarian Cancer
SH56H60_Cell4


title: Ovarian Cancer OV0037

description:
Ovarian Cancer
SH56H47_Cell4


title: Ovarian Cancer OV0038

description:
Ovarian Cancer
SH56H48_Cell1


title: Ovarian Cancer OV0036

description:
Ovarian Cancer
SH56H47_Cell3


title: Ovarian Cancer OV0040

description:
Ovarian Cancer
SH56H48_Cell3


title: Ovarian Cancer OV0041

description:
Ovarian Cancer
SH56H48_Cell4


title: Ovarian Cancer OV0035

description:
Ovarian Cancer
SH56H47_Cell2


title: Ovarian Cancer OV0045

description:
Ovarian Cancer
SH56H49_Cell4


title: Ovarian Cancer OV0031

description:
Ovarian Cancer
SH56H45_Cell2


title: Ovarian Cancer OV0026

description:
Ovarian Cancer
SH56H46_Cell1


title: Ovarian Cancer OV0032

description:
Ovarian Cancer
SH56H45_Cell3


title: Ovarian Cancer OV0028

description:
Ovarian Cancer
SH56H46_Cell3


title: Ovarian Cancer OV0030

description:
Ovarian Cancer
SH56H45_Cell1


title: Ovarian Cancer OV0029

description:
Ovarian Cancer
SH56H46_Cell4


title: Ovarian Cancer OV0025

description:
Ovarian Cancer
SH56H44_Cell4


title: Ovarian Cancer OV0018

description:
Ovarian Cancer
SH56H43_Cell1


title: Ovarian Cancer OV0024

description:
Ovarian Cancer
SH56H44_Cell3


title: Ovarian Cancer OV0023

description:
Ovarian Cancer
SH56H44_Cell2


title: Ovarian Cancer OV0020

description:
Ovarian Cancer
SH56H43_Cell3


title: Ovarian Cancer OV0034

description:
Ovarian Cancer
SH56H47_Cell1


title: Ovarian Cancer OV0010

description:
Ovarian Cancer
SH56H40_Cell1


title: Ovarian Cancer OV0011

description:
Ovarian Cancer
SH56H40_Cell2


title: Ovarian Cancer OV0008

description:
Ovarian Cancer
SH56H39_Cell3


title: Ovarian Cancer OV0019

description:
Ovarian Cancer
SH56H43_Cell2


title: Ovarian Cancer OV0014

description:
Ovarian Cancer
SH56H42_Cell1


title: Ovarian Cancer OV0033

description:
Ovarian Cancer
SH56H45_Cell4


title: Ovarian Cancer OV0012

description:
Ovarian Cancer
SH56H40_Cell3


title: Ovarian Cancer OV0006

description:
Ovarian Cancer
SH56H39_Cell1


title: Ovarian Cancer OV0004

description:
Ovarian Cancer
SH56H37_Cell3


title: Ovarian Cancer OV0002

description:
Ovarian Cancer
SH56H37_Cell1


title: Ovarian Cancer OV0001

description:
Ovarian Cancer
SH56H36_Cell4


title: Ovarian Cancer OV0005

description:
Ovarian Cancer
SH56H37_Cell4


title: Ovarian Cancer OV0007

description:
Ovarian Cancer
SH56H39_Cell2


title: Ovarian Cancer OV0021

description:
Ovarian Cancer
SH56H43_Cell4


title: Ovarian Cancer OV0013

description:
Ovarian Cancer
SH56H40_Cell4


title: Borderline Ovarian Tumor OV0431

description:
Borderline Ovarian Tumor
SH67S38_Cell1


title: Borderline Ovarian Tumor OV0434

description:
Borderline Ovarian Tumor
SH67S38_Cell4


title: Borderline Ovarian Tumor OV0408

description:
Borderline Ovarian Tumor
SH67S29_Cell2


title: Borderline Ovarian Tumor OV0422

description:
Borderline Ovarian Tumor
SH67S33_Cell4


title: Borderline Ovarian Tumor OV0424

description:
Borderline Ovarian Tumor
SH67S34_Cell2


title: Borderline Ovarian Tumor OV0373

description:
Borderline Ovarian Tumor
SH67S18_Cell3


title: Borderline Ovarian Tumor OV0388

description:
Borderline Ovarian Tumor
SH67S23_Cell2


title: Borderline Ovarian Tumor OV0362

description:
Borderline Ovarian Tumor
SH67S14_Cell4


title: Borderline Ovarian Tumor OV0377

description:
Borderline Ovarian Tumor
SH67S19_Cell3


title: Borderline Ovarian Tumor OV0316

description:
Borderline Ovarian Tumor
SH67S01_Cell2


title: Borderline Ovarian Tumor OV0435

description:
Borderline Ovarian Tumor
SH67S39_Cell1


title: Borderline Ovarian Tumor OV0407

description:
Borderline Ovarian Tumor
SH67T20_Cell4


title: Borderline Ovarian Tumor OV0299

description:
Borderline Ovarian Tumor
SH67R60_Cell1


title: Borderline Ovarian Tumor OV0298

description:
Borderline Ovarian Tumor
SH67R59_Cell4


title: Borderline Ovarian Tumor OV0394

description:
Borderline Ovarian Tumor
SH67T20_Cell3


title: Borderline Ovarian Tumor OV0300

description:
Borderline Ovarian Tumor
SH67R60_Cell2


title: Borderline Ovarian Tumor OV0242

description:
Borderline Ovarian Tumor
SH57M27_Cell1


title: Borderline Ovarian Tumor OV0418

description:
Borderline Ovarian Tumor
SH67S32_Cell4


title: Borderline Ovarian Tumor OV0277

description:
Borderline Ovarian Tumor
SH67R53_Cell3


title: Borderline Ovarian Tumor OV0337

description:
Borderline Ovarian Tumor
SH67T18_Cell4


title: Borderline Ovarian Tumor OV0367

description:
Borderline Ovarian Tumor
SH67S16_Cell1


title: Borderline Ovarian Tumor OV0240

description:
Borderline Ovarian Tumor
SH57M26_Cell3


title: Borderline Ovarian Tumor OV0251

description:
Borderline Ovarian Tumor
SH57M29_Cell2


title: Borderline Ovarian Tumor OV0234

description:
Borderline Ovarian Tumor
SH57M24_Cell1


title: Borderline Ovarian Tumor OV0237

description:
Borderline Ovarian Tumor
SH57M24_Cell4


title: Borderline Ovarian Tumor OV0278

description:
Borderline Ovarian Tumor
SH67R53_Cell4


title: Borderline Ovarian Tumor OV0293

description:
Borderline Ovarian Tumor
SH67R58_Cell3


title: Borderline Ovarian Tumor OV0232

description:
Borderline Ovarian Tumor
SH57M23_Cell3


title: Borderline Ovarian Tumor OV0215

description:
Borderline Ovarian Tumor
SH57M19_Cell2


title: Borderline Ovarian Tumor OV0202

description:
Borderline Ovarian Tumor
SH57M16_Cell1


title: Borderline Ovarian Tumor OV0207

description:
Borderline Ovarian Tumor
SH57M17_Cell2


title: Borderline Ovarian Tumor OV0354

description:
Borderline Ovarian Tumor
SH67S12_Cell4


title: Borderline Ovarian Tumor OV0188

description:
Borderline Ovarian Tumor
SH57P14_Cell1


title: Borderline Ovarian Tumor OV0186

description:
Borderline Ovarian Tumor
SH57P13_Cell3


title: Ovarian Cancer OV0088

description:
Ovarian Cancer
SH56H67_Cell4


title: Borderline Ovarian Tumor OV0182

description:
Borderline Ovarian Tumor
SH57M11_Cell1


title: Borderline Ovarian Tumor OV0171

description:
Borderline Ovarian Tumor
SH57M03_Cell3


title: Borderline Ovarian Tumor OV0170

description:
Borderline Ovarian Tumor
SH57M03_Cell2


title: Borderline Ovarian Tumor OV0180

description:
Borderline Ovarian Tumor
SH57M05_Cell4


title: Borderline Ovarian Tumor OV0184

description:
Borderline Ovarian Tumor
SH57P13_Cell1


title: Borderline Ovarian Tumor OV0217

description:
Borderline Ovarian Tumor
SH57M19_Cell4


title: Borderline Ovarian Tumor OV0150

description:
Borderline Ovarian Tumor
SH57G65_Cell2


title: Borderline Ovarian Tumor OV0147

description:
Borderline Ovarian Tumor
SH57G64_Cell3


title: Borderline Ovarian Tumor OV0141

description:
Borderline Ovarian Tumor
SH57G63_Cell1


title: Borderline Ovarian Tumor OV0137

description:
Borderline Ovarian Tumor
SH57G62_Cell1


title: Borderline Ovarian Tumor OV0135

description:
Borderline Ovarian Tumor
SH57G60_Cell3


title: Borderline Ovarian Tumor OV0104

description:
Borderline Ovarian Tumor
SH56J03_Cell4


title: Borderline Ovarian Tumor OV0123

description:
Borderline Ovarian Tumor
SH57G57_Cell3


title: Borderline Ovarian Tumor OV0140

description:
Borderline Ovarian Tumor
SH57G62_Cell4


title: Borderline Ovarian Tumor OV0154

description:
Borderline Ovarian Tumor
SH57G66_Cell2


title: Borderline Ovarian Tumor OV0092

description:
Borderline Ovarian Tumor
SH56H68_Cell4


title: Borderline Ovarian Tumor OV0091

description:
Borderline Ovarian Tumor
SH56H68_Cell3


title: Borderline Ovarian Tumor OV0096

description:
Borderline Ovarian Tumor
SH57P10_Cell3


title: Borderline Ovarian Tumor OV0151

description:
Borderline Ovarian Tumor
SH57G65_Cell3


title: Borderline Ovarian Tumor OV0108

description:
Borderline Ovarian Tumor
SH56J05_Cell4


title: Borderline Ovarian Tumor OV0039

description:
Borderline Ovarian Tumor
SH56H48_Cell2


title: Borderline Ovarian Tumor OV0087

description:
Borderline Ovarian Tumor
SH56H67_Cell3


title: Borderline Ovarian Tumor OV0042

description:
Borderline Ovarian Tumor
SH56H49_Cell1


title: Borderline Ovarian Tumor OV0052

description:
Borderline Ovarian Tumor
SH57P09_Cell2


title: Borderline Ovarian Tumor OV0074

description:
Borderline Ovarian Tumor
SH56H64_Cell2


title: Borderline Ovarian Tumor OV0086

description:
Borderline Ovarian Tumor
SH56H67_Cell2


title: Borderline Ovarian Tumor OV0063

description:
Borderline Ovarian Tumor
SH56H60_Cell3


title: Borderline Ovarian Tumor OV0027

description:
Borderline Ovarian Tumor
SH56H46_Cell2


title: Borderline Ovarian Tumor OV0017

description:
Borderline Ovarian Tumor
SH56H42_Cell4


title: Borderline Ovarian Tumor OV0015

description:
Borderline Ovarian Tumor
SH56H42_Cell2


title: Borderline Ovarian Tumor OV0100

description:
Borderline Ovarian Tumor
SH57P12_Cell3


title: Borderline Ovarian Tumor OV0003

description:
Borderline Ovarian Tumor
SH56H37_Cell2


title: Benign Ovarian Disease OV0437

description:
Benign Ovarian Disease
SH67S39_Cell3


title: Benign Ovarian Disease OV0428

description:
Benign Ovarian Disease
SH67S37_Cell2


title: Benign Ovarian Disease OV0425

description:
Benign Ovarian Disease
SH67S34_Cell3


title: Benign Ovarian Disease OV0363

description:
Benign Ovarian Disease
SH67S15_Cell1


title: Benign Ovarian Disease OV0358

description:
Benign Ovarian Disease
SH67S13_Cell4


title: Benign Ovarian Disease OV0356

description:
Benign Ovarian Disease
SH67S13_Cell2


title: Benign Ovarian Disease OV0364

description:
Benign Ovarian Disease
SH67S15_Cell2


title: Benign Ovarian Disease OV0334

description:
Benign Ovarian Disease
SH67S05_Cell4


title: Benign Ovarian Disease OV0328

description:
Benign Ovarian Disease
SH67S04_Cell2


title: Benign Ovarian Disease OV0305

description:
Benign Ovarian Disease
SH67R61_Cell3


title: Benign Ovarian Disease OV0348

description:
Benign Ovarian Disease
SH67S11_Cell2


title: Benign Ovarian Disease OV0302

description:
Benign Ovarian Disease
SH67R60_Cell4


title: Benign Ovarian Disease OV0421

description:
Benign Ovarian Disease
SH67S33_Cell3


title: Benign Ovarian Disease OV0306

description:
Benign Ovarian Disease
SH67R61_Cell4


title: Benign Ovarian Disease OV0352

description:
Benign Ovarian Disease
SH67S12_Cell2


title: Benign Ovarian Disease OV0301

description:
Benign Ovarian Disease
SH67R60_Cell3


title: Benign Ovarian Disease OV0287

description:
Benign Ovarian Disease
SH67R56_Cell1


title: Benign Ovarian Disease OV0282

description:
Benign Ovarian Disease
SH67R54_Cell4


title: Benign Ovarian Disease OV0268

description:
Benign Ovarian Disease
SH67R51_Cell2


title: Benign Ovarian Disease OV0276

description:
Benign Ovarian Disease
SH67R53_Cell2


title: Benign Ovarian Disease OV0270

description:
Benign Ovarian Disease
SH67R51_Cell4


title: Benign Ovarian Disease OV0286

description:
Benign Ovarian Disease
SH67R55_Cell4


title: non-Cancer NB14120504

description:
non-Cancer
SH64706_Cell4


title: Benign Ovarian Disease OV0263

description:
Benign Ovarian Disease
SH67R50_Cell1


title: Benign Ovarian Disease OV0303

description:
Benign Ovarian Disease
SH67R61_Cell1


title: Benign Ovarian Disease OV0289

description:
Benign Ovarian Disease
SH67R56_Cell3


title: Benign Ovarian Disease OV0341

description:
Benign Ovarian Disease
SH67S08_Cell3